pert_well	pert_id	pert_iname	pert_type	pert_idose	pert_mfc_id	pert_mfc_desc	pert_dose	pert_dose_unit	pert_vehicle	pert_plate	moa	target_name	reason_to_include	x_plate_map_name	x_pert_iname_with_rep	x_sig_group
A01	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.06	DMSO.06:-666
A02	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.02	DMSO.02:-666
A03	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.08	DMSO.08:-666
A04	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.08	DMSO.08:-666
A05	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.02	DMSO.02:-666
A06	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.08	DMSO.08:-666
A07	BRD-K59369769	tozasertib	trt_cp	10.0 uM	BRD-K59369769-001-05-4	tozasertib	10	uM	DMSO	PGR001	Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor	ABL1|AURKA|AURKB|AURKC|BCR|FLT3|JAK2	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	tozasertib	tozasertib:10.0 uM
A08	BRD-K59369769	tozasertib	trt_cp	3.333 uM	BRD-K59369769-001-05-4	tozasertib	3.33333	uM	DMSO	PGR001	Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor	ABL1|AURKA|AURKB|AURKC|BCR|FLT3|JAK2	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	tozasertib	tozasertib:3.333 uM
A09	BRD-K59369769	tozasertib	trt_cp	1.111 uM	BRD-K59369769-001-05-4	tozasertib	1.11111	uM	DMSO	PGR001	Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor	ABL1|AURKA|AURKB|AURKC|BCR|FLT3|JAK2	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	tozasertib	tozasertib:1.111 uM
A10	BRD-K59369769	tozasertib	trt_cp	0.37 uM	BRD-K59369769-001-05-4	tozasertib	0.37037	uM	DMSO	PGR001	Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor	ABL1|AURKA|AURKB|AURKC|BCR|FLT3|JAK2	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	tozasertib	tozasertib:0.37 uM
A11	BRD-K59369769	tozasertib	trt_cp	0.123 uM	BRD-K59369769-001-05-4	tozasertib	0.123457	uM	DMSO	PGR001	Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor	ABL1|AURKA|AURKB|AURKC|BCR|FLT3|JAK2	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	tozasertib	tozasertib:0.123 uM
A12	BRD-K59369769	tozasertib	trt_cp	0.041 uM	BRD-K59369769-001-05-4	tozasertib	0.0411523	uM	DMSO	PGR001	Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor	ABL1|AURKA|AURKB|AURKC|BCR|FLT3|JAK2	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	tozasertib	tozasertib:0.041 uM
A13	BRD-K70401845	erlotinib	trt_cp	10.0 uM	BRD-K70401845-003-02-1	erlotinib	10	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.1	erlotinib.1:10.0 uM
A14	BRD-K70401845	erlotinib	trt_cp	3.333 uM	BRD-K70401845-003-02-1	erlotinib	3.33333	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.1	erlotinib.1:3.333 uM
A15	BRD-K70401845	erlotinib	trt_cp	1.111 uM	BRD-K70401845-003-02-1	erlotinib	1.11111	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.1	erlotinib.1:1.111 uM
A16	BRD-K70401845	erlotinib	trt_cp	0.37 uM	BRD-K70401845-003-02-1	erlotinib	0.37037	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.1	erlotinib.1:0.37 uM
A17	BRD-K70401845	erlotinib	trt_cp	0.123 uM	BRD-K70401845-003-02-1	erlotinib	0.123457	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.1	erlotinib.1:0.123 uM
A18	BRD-K70401845	erlotinib	trt_cp	0.041 uM	BRD-K70401845-003-02-1	erlotinib	0.0411523	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.1	erlotinib.1:0.041 uM
A19	BRD-K19687926	lapatinib	trt_cp	10.0 uM	BRD-K19687926-001-13-2	lapatinib	10	uM	DMSO	PGR001	EGFR inhibitor|ErbB2 inhibitor	EGFR|ERBB2	Harris2016; 24h > 120h in Pr500 pilot	C-5001-01-LM6-031	lapatinib	lapatinib:10.0 uM
A20	BRD-K19687926	lapatinib	trt_cp	3.333 uM	BRD-K19687926-001-13-2	lapatinib	3.33333	uM	DMSO	PGR001	EGFR inhibitor|ErbB2 inhibitor	EGFR|ERBB2	Harris2016; 24h > 120h in Pr500 pilot	C-5001-01-LM6-031	lapatinib	lapatinib:3.333 uM
A21	BRD-K19687926	lapatinib	trt_cp	1.111 uM	BRD-K19687926-001-13-2	lapatinib	1.11111	uM	DMSO	PGR001	EGFR inhibitor|ErbB2 inhibitor	EGFR|ERBB2	Harris2016; 24h > 120h in Pr500 pilot	C-5001-01-LM6-031	lapatinib	lapatinib:1.111 uM
A22	BRD-K19687926	lapatinib	trt_cp	0.37 uM	BRD-K19687926-001-13-2	lapatinib	0.37037	uM	DMSO	PGR001	EGFR inhibitor|ErbB2 inhibitor	EGFR|ERBB2	Harris2016; 24h > 120h in Pr500 pilot	C-5001-01-LM6-031	lapatinib	lapatinib:0.37 uM
A23	BRD-K19687926	lapatinib	trt_cp	0.123 uM	BRD-K19687926-001-13-2	lapatinib	0.123457	uM	DMSO	PGR001	EGFR inhibitor|ErbB2 inhibitor	EGFR|ERBB2	Harris2016; 24h > 120h in Pr500 pilot	C-5001-01-LM6-031	lapatinib	lapatinib:0.123 uM
A24	BRD-K19687926	lapatinib	trt_cp	0.041 uM	BRD-K19687926-001-13-2	lapatinib	0.0411523	uM	DMSO	PGR001	EGFR inhibitor|ErbB2 inhibitor	EGFR|ERBB2	Harris2016; 24h > 120h in Pr500 pilot	C-5001-01-LM6-031	lapatinib	lapatinib:0.041 uM
B01	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.04	DMSO.04:-666
B02	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.02	DMSO.02:-666
B03	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.10	DMSO.10:-666
B04	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.06	DMSO.06:-666
B05	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.05	DMSO.05:-666
B06	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.07	DMSO.07:-666
B07	BRD-K16478699	PLX-4720	trt_cp	10.0 uM	BRD-K16478699-001-01-9	PLX-4720	10	uM	DMSO	PGR001	RAF inhibitor	BRAF	Hafner2016; Harris et al	C-5001-01-LM6-031	PLX-4720	PLX-4720:10.0 uM
B08	BRD-K16478699	PLX-4720	trt_cp	3.333 uM	BRD-K16478699-001-01-9	PLX-4720	3.33333	uM	DMSO	PGR001	RAF inhibitor	BRAF	Hafner2016; Harris et al	C-5001-01-LM6-031	PLX-4720	PLX-4720:3.333 uM
B09	BRD-K16478699	PLX-4720	trt_cp	1.111 uM	BRD-K16478699-001-01-9	PLX-4720	1.11111	uM	DMSO	PGR001	RAF inhibitor	BRAF	Hafner2016; Harris et al	C-5001-01-LM6-031	PLX-4720	PLX-4720:1.111 uM
B10	BRD-K16478699	PLX-4720	trt_cp	0.37 uM	BRD-K16478699-001-01-9	PLX-4720	0.37037	uM	DMSO	PGR001	RAF inhibitor	BRAF	Hafner2016; Harris et al	C-5001-01-LM6-031	PLX-4720	PLX-4720:0.37 uM
B11	BRD-K16478699	PLX-4720	trt_cp	0.123 uM	BRD-K16478699-001-01-9	PLX-4720	0.123457	uM	DMSO	PGR001	RAF inhibitor	BRAF	Hafner2016; Harris et al	C-5001-01-LM6-031	PLX-4720	PLX-4720:0.123 uM
B12	BRD-K16478699	PLX-4720	trt_cp	0.041 uM	BRD-K16478699-001-01-9	PLX-4720	0.0411523	uM	DMSO	PGR001	RAF inhibitor	BRAF	Hafner2016; Harris et al	C-5001-01-LM6-031	PLX-4720	PLX-4720:0.041 uM
B13	BRD-K51313569	palbociclib	trt_cp	10.0 uM	BRD-K51313569-001-01-1	palbociclib	10	uM	DMSO	PGR001	CDK inhibitor	CDK4|CDK6	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	palbociclib	palbociclib:10.0 uM
B14	BRD-K51313569	palbociclib	trt_cp	3.333 uM	BRD-K51313569-001-01-1	palbociclib	3.33333	uM	DMSO	PGR001	CDK inhibitor	CDK4|CDK6	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	palbociclib	palbociclib:3.333 uM
B15	BRD-K51313569	palbociclib	trt_cp	1.111 uM	BRD-K51313569-001-01-1	palbociclib	1.11111	uM	DMSO	PGR001	CDK inhibitor	CDK4|CDK6	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	palbociclib	palbociclib:1.111 uM
B16	BRD-K51313569	palbociclib	trt_cp	0.37 uM	BRD-K51313569-001-01-1	palbociclib	0.37037	uM	DMSO	PGR001	CDK inhibitor	CDK4|CDK6	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	palbociclib	palbociclib:0.37 uM
B17	BRD-K51313569	palbociclib	trt_cp	0.123 uM	BRD-K51313569-001-01-1	palbociclib	0.123457	uM	DMSO	PGR001	CDK inhibitor	CDK4|CDK6	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	palbociclib	palbociclib:0.123 uM
B18	BRD-K51313569	palbociclib	trt_cp	0.041 uM	BRD-K51313569-001-01-1	palbociclib	0.0411523	uM	DMSO	PGR001	CDK inhibitor	CDK4|CDK6	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	palbociclib	palbociclib:0.041 uM
B19	BRD-K08316444	rotenone	trt_cp	10.0 uM	BRD-K08316444-001-03-5	rotenone	10	uM	DMSO	PGR001	Mitochondrial complex I inhibitor	MT-ND1	Harris2016	C-5001-01-LM6-031	rotenone	rotenone:10.0 uM
B20	BRD-K08316444	rotenone	trt_cp	3.333 uM	BRD-K08316444-001-03-5	rotenone	3.33333	uM	DMSO	PGR001	Mitochondrial complex I inhibitor	MT-ND1	Harris2016	C-5001-01-LM6-031	rotenone	rotenone:3.333 uM
B21	BRD-K08316444	rotenone	trt_cp	1.111 uM	BRD-K08316444-001-03-5	rotenone	1.11111	uM	DMSO	PGR001	Mitochondrial complex I inhibitor	MT-ND1	Harris2016	C-5001-01-LM6-031	rotenone	rotenone:1.111 uM
B22	BRD-K08316444	rotenone	trt_cp	0.37 uM	BRD-K08316444-001-03-5	rotenone	0.37037	uM	DMSO	PGR001	Mitochondrial complex I inhibitor	MT-ND1	Harris2016	C-5001-01-LM6-031	rotenone	rotenone:0.37 uM
B23	BRD-K08316444	rotenone	trt_cp	0.123 uM	BRD-K08316444-001-03-5	rotenone	0.123457	uM	DMSO	PGR001	Mitochondrial complex I inhibitor	MT-ND1	Harris2016	C-5001-01-LM6-031	rotenone	rotenone:0.123 uM
B24	BRD-K08316444	rotenone	trt_cp	0.041 uM	BRD-K08316444-001-03-5	rotenone	0.0411523	uM	DMSO	PGR001	Mitochondrial complex I inhibitor	MT-ND1	Harris2016	C-5001-01-LM6-031	rotenone	rotenone:0.041 uM
C01	BRD-K37890730	camptothecin	trt_cp	10.0 uM	BRD-K37890730-001-21-9	camptothecin	10	uM	DMSO	PGR001	Topoisomerase inhibitor	TOP1	Forcina2017	C-5001-01-LM6-031	camptothecin	camptothecin:10.0 uM
C02	BRD-K37890730	camptothecin	trt_cp	3.333 uM	BRD-K37890730-001-21-9	camptothecin	3.33333	uM	DMSO	PGR001	Topoisomerase inhibitor	TOP1	Forcina2017	C-5001-01-LM6-031	camptothecin	camptothecin:3.333 uM
C03	BRD-K37890730	camptothecin	trt_cp	1.111 uM	BRD-K37890730-001-21-9	camptothecin	1.11111	uM	DMSO	PGR001	Topoisomerase inhibitor	TOP1	Forcina2017	C-5001-01-LM6-031	camptothecin	camptothecin:1.111 uM
C04	BRD-K37890730	camptothecin	trt_cp	0.37 uM	BRD-K37890730-001-21-9	camptothecin	0.37037	uM	DMSO	PGR001	Topoisomerase inhibitor	TOP1	Forcina2017	C-5001-01-LM6-031	camptothecin	camptothecin:0.37 uM
C05	BRD-K37890730	camptothecin	trt_cp	0.123 uM	BRD-K37890730-001-21-9	camptothecin	0.123457	uM	DMSO	PGR001	Topoisomerase inhibitor	TOP1	Forcina2017	C-5001-01-LM6-031	camptothecin	camptothecin:0.123 uM
C06	BRD-K37890730	camptothecin	trt_cp	0.041 uM	BRD-K37890730-001-21-9	camptothecin	0.0411523	uM	DMSO	PGR001	Topoisomerase inhibitor	TOP1	Forcina2017	C-5001-01-LM6-031	camptothecin	camptothecin:0.041 uM
C07	BRD-K59369769	tozasertib	trt_cp	10.0 uM	BRD-K59369769-001-05-4	tozasertib	10	uM	DMSO	PGR001	Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor	ABL1|AURKA|AURKB|AURKC|BCR|FLT3|JAK2	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	tozasertib	tozasertib:10.0 uM
C08	BRD-K59369769	tozasertib	trt_cp	3.333 uM	BRD-K59369769-001-05-4	tozasertib	3.33333	uM	DMSO	PGR001	Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor	ABL1|AURKA|AURKB|AURKC|BCR|FLT3|JAK2	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	tozasertib	tozasertib:3.333 uM
C09	BRD-K59369769	tozasertib	trt_cp	1.111 uM	BRD-K59369769-001-05-4	tozasertib	1.11111	uM	DMSO	PGR001	Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor	ABL1|AURKA|AURKB|AURKC|BCR|FLT3|JAK2	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	tozasertib	tozasertib:1.111 uM
C10	BRD-K59369769	tozasertib	trt_cp	0.37 uM	BRD-K59369769-001-05-4	tozasertib	0.37037	uM	DMSO	PGR001	Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor	ABL1|AURKA|AURKB|AURKC|BCR|FLT3|JAK2	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	tozasertib	tozasertib:0.37 uM
C11	BRD-K59369769	tozasertib	trt_cp	0.123 uM	BRD-K59369769-001-05-4	tozasertib	0.123457	uM	DMSO	PGR001	Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor	ABL1|AURKA|AURKB|AURKC|BCR|FLT3|JAK2	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	tozasertib	tozasertib:0.123 uM
C12	BRD-K59369769	tozasertib	trt_cp	0.041 uM	BRD-K59369769-001-05-4	tozasertib	0.0411523	uM	DMSO	PGR001	Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor	ABL1|AURKA|AURKB|AURKC|BCR|FLT3|JAK2	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	tozasertib	tozasertib:0.041 uM
C13	BRD-A12230535	nutlin-3	trt_cp	10.0 uM	BRD-A12230535-001-16-6	nutlin-3	10	uM	DMSO	PGR001	MDM inhibitor	MDM2	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	nutlin-3	nutlin-3:10.0 uM
C14	BRD-A12230535	nutlin-3	trt_cp	3.333 uM	BRD-A12230535-001-16-6	nutlin-3	3.33333	uM	DMSO	PGR001	MDM inhibitor	MDM2	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	nutlin-3	nutlin-3:3.333 uM
C15	BRD-A12230535	nutlin-3	trt_cp	1.111 uM	BRD-A12230535-001-16-6	nutlin-3	1.11111	uM	DMSO	PGR001	MDM inhibitor	MDM2	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	nutlin-3	nutlin-3:1.111 uM
C16	BRD-A12230535	nutlin-3	trt_cp	0.37 uM	BRD-A12230535-001-16-6	nutlin-3	0.37037	uM	DMSO	PGR001	MDM inhibitor	MDM2	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	nutlin-3	nutlin-3:0.37 uM
C17	BRD-A12230535	nutlin-3	trt_cp	0.123 uM	BRD-A12230535-001-16-6	nutlin-3	0.123457	uM	DMSO	PGR001	MDM inhibitor	MDM2	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	nutlin-3	nutlin-3:0.123 uM
C18	BRD-A12230535	nutlin-3	trt_cp	0.041 uM	BRD-A12230535-001-16-6	nutlin-3	0.0411523	uM	DMSO	PGR001	MDM inhibitor	MDM2	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	nutlin-3	nutlin-3:0.041 uM
C19	BRD-K88510285	bortezomib	trt_poscon	10.0 uM	BRD-K88510285-001-61-6	bortezomib	10.0016	uM	DMSO	PGR001	NFkB pathway inhibitor|Proteasome inhibitor	PSMB5|PSMB1|PSMB2	positive control for SSMD	C-5001-01-LM6-031	bortezomib.2	bortezomib.2:10.0 uM
C20	BRD-K88510285	bortezomib	trt_poscon	10.0 uM	BRD-K88510285-001-61-6	bortezomib	10.0016	uM	DMSO	PGR001	NFkB pathway inhibitor|Proteasome inhibitor	PSMB5|PSMB1|PSMB2	positive control for SSMD	C-5001-01-LM6-031	bortezomib.3	bortezomib.3:10.0 uM
C21	BRD-K88510285	bortezomib	trt_poscon	10.0 uM	BRD-K88510285-001-61-6	bortezomib	10.0016	uM	DMSO	PGR001	NFkB pathway inhibitor|Proteasome inhibitor	PSMB5|PSMB1|PSMB2	positive control for SSMD	C-5001-01-LM6-031	bortezomib.1	bortezomib.1:10.0 uM
C22	BRD-K88510285	bortezomib	trt_poscon	10.0 uM	BRD-K88510285-001-61-6	bortezomib	10.0016	uM	DMSO	PGR001	NFkB pathway inhibitor|Proteasome inhibitor	PSMB5|PSMB1|PSMB2	positive control for SSMD	C-5001-01-LM6-031	bortezomib.2	bortezomib.2:10.0 uM
C23	BRD-K88510285	bortezomib	trt_poscon	10.0 uM	BRD-K88510285-001-61-6	bortezomib	10.0016	uM	DMSO	PGR001	NFkB pathway inhibitor|Proteasome inhibitor	PSMB5|PSMB1|PSMB2	positive control for SSMD	C-5001-01-LM6-031	bortezomib.3	bortezomib.3:10.0 uM
C24	BRD-K88510285	bortezomib	trt_poscon	10.0 uM	BRD-K88510285-001-61-6	bortezomib	10.0016	uM	DMSO	PGR001	NFkB pathway inhibitor|Proteasome inhibitor	PSMB5|PSMB1|PSMB2	positive control for SSMD	C-5001-01-LM6-031	bortezomib.4	bortezomib.4:10.0 uM
D01	BRD-K86118762	linsitinib	trt_cp	10.0 uM	BRD-K86118762-001-07-5	linsitinib	10	uM	DMSO	PGR001	IGF-1 inhibitor	IGF1R|INSR	Hafner2016	C-5001-01-LM6-031	linsitinib	linsitinib:10.0 uM
D02	BRD-K86118762	linsitinib	trt_cp	3.333 uM	BRD-K86118762-001-07-5	linsitinib	3.33333	uM	DMSO	PGR001	IGF-1 inhibitor	IGF1R|INSR	Hafner2016	C-5001-01-LM6-031	linsitinib	linsitinib:3.333 uM
D03	BRD-K86118762	linsitinib	trt_cp	1.111 uM	BRD-K86118762-001-07-5	linsitinib	1.11111	uM	DMSO	PGR001	IGF-1 inhibitor	IGF1R|INSR	Hafner2016	C-5001-01-LM6-031	linsitinib	linsitinib:1.111 uM
D04	BRD-K86118762	linsitinib	trt_cp	0.37 uM	BRD-K86118762-001-07-5	linsitinib	0.37037	uM	DMSO	PGR001	IGF-1 inhibitor	IGF1R|INSR	Hafner2016	C-5001-01-LM6-031	linsitinib	linsitinib:0.37 uM
D05	BRD-K86118762	linsitinib	trt_cp	0.123 uM	BRD-K86118762-001-07-5	linsitinib	0.123457	uM	DMSO	PGR001	IGF-1 inhibitor	IGF1R|INSR	Hafner2016	C-5001-01-LM6-031	linsitinib	linsitinib:0.123 uM
D06	BRD-K86118762	linsitinib	trt_cp	0.041 uM	BRD-K86118762-001-07-5	linsitinib	0.0411523	uM	DMSO	PGR001	IGF-1 inhibitor	IGF1R|INSR	Hafner2016	C-5001-01-LM6-031	linsitinib	linsitinib:0.041 uM
D07	BRD-A25004090	erastin	trt_cp	10.0 uM	BRD-A25004090-001-03-5	erastin	10	uM	DMSO	PGR001	Ion channel antagonist	VDAC2	Forcina2017	C-5001-01-LM6-031	erastin	erastin:10.0 uM
D08	BRD-A25004090	erastin	trt_cp	3.333 uM	BRD-A25004090-001-03-5	erastin	3.33333	uM	DMSO	PGR001	Ion channel antagonist	VDAC2	Forcina2017	C-5001-01-LM6-031	erastin	erastin:3.333 uM
D09	BRD-A25004090	erastin	trt_cp	1.111 uM	BRD-A25004090-001-03-5	erastin	1.11111	uM	DMSO	PGR001	Ion channel antagonist	VDAC2	Forcina2017	C-5001-01-LM6-031	erastin	erastin:1.111 uM
D10	BRD-A25004090	erastin	trt_cp	0.37 uM	BRD-A25004090-001-03-5	erastin	0.37037	uM	DMSO	PGR001	Ion channel antagonist	VDAC2	Forcina2017	C-5001-01-LM6-031	erastin	erastin:0.37 uM
D11	BRD-A25004090	erastin	trt_cp	0.123 uM	BRD-A25004090-001-03-5	erastin	0.123457	uM	DMSO	PGR001	Ion channel antagonist	VDAC2	Forcina2017	C-5001-01-LM6-031	erastin	erastin:0.123 uM
D12	BRD-A25004090	erastin	trt_cp	0.041 uM	BRD-A25004090-001-03-5	erastin	0.0411523	uM	DMSO	PGR001	Ion channel antagonist	VDAC2	Forcina2017	C-5001-01-LM6-031	erastin	erastin:0.041 uM
D13	BRD-K16478699	PLX-4720	trt_cp	10.0 uM	BRD-K16478699-001-01-9	PLX-4720	10	uM	DMSO	PGR001	RAF inhibitor	BRAF	Hafner2016; Harris et al	C-5001-01-LM6-031	PLX-4720	PLX-4720:10.0 uM
D14	BRD-K16478699	PLX-4720	trt_cp	3.333 uM	BRD-K16478699-001-01-9	PLX-4720	3.33333	uM	DMSO	PGR001	RAF inhibitor	BRAF	Hafner2016; Harris et al	C-5001-01-LM6-031	PLX-4720	PLX-4720:3.333 uM
D15	BRD-K16478699	PLX-4720	trt_cp	1.111 uM	BRD-K16478699-001-01-9	PLX-4720	1.11111	uM	DMSO	PGR001	RAF inhibitor	BRAF	Hafner2016; Harris et al	C-5001-01-LM6-031	PLX-4720	PLX-4720:1.111 uM
D16	BRD-K16478699	PLX-4720	trt_cp	0.37 uM	BRD-K16478699-001-01-9	PLX-4720	0.37037	uM	DMSO	PGR001	RAF inhibitor	BRAF	Hafner2016; Harris et al	C-5001-01-LM6-031	PLX-4720	PLX-4720:0.37 uM
D17	BRD-K16478699	PLX-4720	trt_cp	0.123 uM	BRD-K16478699-001-01-9	PLX-4720	0.123457	uM	DMSO	PGR001	RAF inhibitor	BRAF	Hafner2016; Harris et al	C-5001-01-LM6-031	PLX-4720	PLX-4720:0.123 uM
D18	BRD-K16478699	PLX-4720	trt_cp	0.041 uM	BRD-K16478699-001-01-9	PLX-4720	0.0411523	uM	DMSO	PGR001	RAF inhibitor	BRAF	Hafner2016; Harris et al	C-5001-01-LM6-031	PLX-4720	PLX-4720:0.041 uM
D19	BRD-A63610676	paclitaxel	trt_cp	10.0 uM	BRD-A63610676-001-15-8	paclitaxel	10	uM	DMSO	PGR001	Tubulin inhibitor	NR1I2|TUBB	Chan2013	C-5001-01-LM6-031	paclitaxel	paclitaxel:10.0 uM
D20	BRD-A63610676	paclitaxel	trt_cp	3.333 uM	BRD-A63610676-001-15-8	paclitaxel	3.33333	uM	DMSO	PGR001	Tubulin inhibitor	NR1I2|TUBB	Chan2013	C-5001-01-LM6-031	paclitaxel	paclitaxel:3.333 uM
D21	BRD-A63610676	paclitaxel	trt_cp	1.111 uM	BRD-A63610676-001-15-8	paclitaxel	1.11111	uM	DMSO	PGR001	Tubulin inhibitor	NR1I2|TUBB	Chan2013	C-5001-01-LM6-031	paclitaxel	paclitaxel:1.111 uM
D22	BRD-A63610676	paclitaxel	trt_cp	0.37 uM	BRD-A63610676-001-15-8	paclitaxel	0.37037	uM	DMSO	PGR001	Tubulin inhibitor	NR1I2|TUBB	Chan2013	C-5001-01-LM6-031	paclitaxel	paclitaxel:0.37 uM
D23	BRD-A63610676	paclitaxel	trt_cp	0.123 uM	BRD-A63610676-001-15-8	paclitaxel	0.123457	uM	DMSO	PGR001	Tubulin inhibitor	NR1I2|TUBB	Chan2013	C-5001-01-LM6-031	paclitaxel	paclitaxel:0.123 uM
D24	BRD-A63610676	paclitaxel	trt_cp	0.041 uM	BRD-A63610676-001-15-8	paclitaxel	0.0411523	uM	DMSO	PGR001	Tubulin inhibitor	NR1I2|TUBB	Chan2013	C-5001-01-LM6-031	paclitaxel	paclitaxel:0.041 uM
E01	BRD-A25004090	erastin	trt_cp	10.0 uM	BRD-A25004090-001-03-5	erastin	10	uM	DMSO	PGR001	Ion channel antagonist	VDAC2	Forcina2017	C-5001-01-LM6-031	erastin	erastin:10.0 uM
E02	BRD-A25004090	erastin	trt_cp	3.333 uM	BRD-A25004090-001-03-5	erastin	3.33333	uM	DMSO	PGR001	Ion channel antagonist	VDAC2	Forcina2017	C-5001-01-LM6-031	erastin	erastin:3.333 uM
E03	BRD-A25004090	erastin	trt_cp	1.111 uM	BRD-A25004090-001-03-5	erastin	1.11111	uM	DMSO	PGR001	Ion channel antagonist	VDAC2	Forcina2017	C-5001-01-LM6-031	erastin	erastin:1.111 uM
E04	BRD-A25004090	erastin	trt_cp	0.37 uM	BRD-A25004090-001-03-5	erastin	0.37037	uM	DMSO	PGR001	Ion channel antagonist	VDAC2	Forcina2017	C-5001-01-LM6-031	erastin	erastin:0.37 uM
E05	BRD-A25004090	erastin	trt_cp	0.123 uM	BRD-A25004090-001-03-5	erastin	0.123457	uM	DMSO	PGR001	Ion channel antagonist	VDAC2	Forcina2017	C-5001-01-LM6-031	erastin	erastin:0.123 uM
E06	BRD-A25004090	erastin	trt_cp	0.041 uM	BRD-A25004090-001-03-5	erastin	0.0411523	uM	DMSO	PGR001	Ion channel antagonist	VDAC2	Forcina2017	C-5001-01-LM6-031	erastin	erastin:0.041 uM
E07	BRD-K37890730	camptothecin	trt_cp	10.0 uM	BRD-K37890730-001-21-9	camptothecin	10	uM	DMSO	PGR001	Topoisomerase inhibitor	TOP1	Forcina2017	C-5001-01-LM6-031	camptothecin	camptothecin:10.0 uM
E08	BRD-K37890730	camptothecin	trt_cp	3.333 uM	BRD-K37890730-001-21-9	camptothecin	3.33333	uM	DMSO	PGR001	Topoisomerase inhibitor	TOP1	Forcina2017	C-5001-01-LM6-031	camptothecin	camptothecin:3.333 uM
E09	BRD-K37890730	camptothecin	trt_cp	1.111 uM	BRD-K37890730-001-21-9	camptothecin	1.11111	uM	DMSO	PGR001	Topoisomerase inhibitor	TOP1	Forcina2017	C-5001-01-LM6-031	camptothecin	camptothecin:1.111 uM
E10	BRD-K37890730	camptothecin	trt_cp	0.37 uM	BRD-K37890730-001-21-9	camptothecin	0.37037	uM	DMSO	PGR001	Topoisomerase inhibitor	TOP1	Forcina2017	C-5001-01-LM6-031	camptothecin	camptothecin:0.37 uM
E11	BRD-K37890730	camptothecin	trt_cp	0.123 uM	BRD-K37890730-001-21-9	camptothecin	0.123457	uM	DMSO	PGR001	Topoisomerase inhibitor	TOP1	Forcina2017	C-5001-01-LM6-031	camptothecin	camptothecin:0.123 uM
E12	BRD-K37890730	camptothecin	trt_cp	0.041 uM	BRD-K37890730-001-21-9	camptothecin	0.0411523	uM	DMSO	PGR001	Topoisomerase inhibitor	TOP1	Forcina2017	C-5001-01-LM6-031	camptothecin	camptothecin:0.041 uM
E13	BRD-K15616905	CCCP	trt_cp	10.0 uM	BRD-K15616905-001-03-1	CCCP	10	uM	DMSO	PGR001	Mitochondrial oxidative phosphorylation uncoupler	-666	Forcina2017	C-5001-01-LM6-031	CCCP	CCCP:10.0 uM
E14	BRD-K15616905	CCCP	trt_cp	3.333 uM	BRD-K15616905-001-03-1	CCCP	3.33333	uM	DMSO	PGR001	Mitochondrial oxidative phosphorylation uncoupler	-666	Forcina2017	C-5001-01-LM6-031	CCCP	CCCP:3.333 uM
E15	BRD-K15616905	CCCP	trt_cp	1.111 uM	BRD-K15616905-001-03-1	CCCP	1.11111	uM	DMSO	PGR001	Mitochondrial oxidative phosphorylation uncoupler	-666	Forcina2017	C-5001-01-LM6-031	CCCP	CCCP:1.111 uM
E16	BRD-K15616905	CCCP	trt_cp	0.37 uM	BRD-K15616905-001-03-1	CCCP	0.37037	uM	DMSO	PGR001	Mitochondrial oxidative phosphorylation uncoupler	-666	Forcina2017	C-5001-01-LM6-031	CCCP	CCCP:0.37 uM
E17	BRD-K15616905	CCCP	trt_cp	0.123 uM	BRD-K15616905-001-03-1	CCCP	0.123457	uM	DMSO	PGR001	Mitochondrial oxidative phosphorylation uncoupler	-666	Forcina2017	C-5001-01-LM6-031	CCCP	CCCP:0.123 uM
E18	BRD-K15616905	CCCP	trt_cp	0.041 uM	BRD-K15616905-001-03-1	CCCP	0.0411523	uM	DMSO	PGR001	Mitochondrial oxidative phosphorylation uncoupler	-666	Forcina2017	C-5001-01-LM6-031	CCCP	CCCP:0.041 uM
E19	BRD-K51313569	palbociclib	trt_cp	10.0 uM	BRD-K51313569-001-01-1	palbociclib	10	uM	DMSO	PGR001	CDK inhibitor	CDK4|CDK6	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	palbociclib	palbociclib:10.0 uM
E20	BRD-K51313569	palbociclib	trt_cp	3.333 uM	BRD-K51313569-001-01-1	palbociclib	3.33333	uM	DMSO	PGR001	CDK inhibitor	CDK4|CDK6	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	palbociclib	palbociclib:3.333 uM
E21	BRD-K51313569	palbociclib	trt_cp	1.111 uM	BRD-K51313569-001-01-1	palbociclib	1.11111	uM	DMSO	PGR001	CDK inhibitor	CDK4|CDK6	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	palbociclib	palbociclib:1.111 uM
E22	BRD-K51313569	palbociclib	trt_cp	0.37 uM	BRD-K51313569-001-01-1	palbociclib	0.37037	uM	DMSO	PGR001	CDK inhibitor	CDK4|CDK6	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	palbociclib	palbociclib:0.37 uM
E23	BRD-K51313569	palbociclib	trt_cp	0.123 uM	BRD-K51313569-001-01-1	palbociclib	0.123457	uM	DMSO	PGR001	CDK inhibitor	CDK4|CDK6	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	palbociclib	palbociclib:0.123 uM
E24	BRD-K51313569	palbociclib	trt_cp	0.041 uM	BRD-K51313569-001-01-1	palbociclib	0.0411523	uM	DMSO	PGR001	CDK inhibitor	CDK4|CDK6	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	palbociclib	palbociclib:0.041 uM
F01	BRD-K19687926	lapatinib	trt_cp	10.0 uM	BRD-K19687926-001-13-2	lapatinib	10	uM	DMSO	PGR001	EGFR inhibitor|ErbB2 inhibitor	EGFR|ERBB2	Harris2016; 24h > 120h in Pr500 pilot	C-5001-01-LM6-031	lapatinib	lapatinib:10.0 uM
F02	BRD-K19687926	lapatinib	trt_cp	3.333 uM	BRD-K19687926-001-13-2	lapatinib	3.33333	uM	DMSO	PGR001	EGFR inhibitor|ErbB2 inhibitor	EGFR|ERBB2	Harris2016; 24h > 120h in Pr500 pilot	C-5001-01-LM6-031	lapatinib	lapatinib:3.333 uM
F03	BRD-K19687926	lapatinib	trt_cp	1.111 uM	BRD-K19687926-001-13-2	lapatinib	1.11111	uM	DMSO	PGR001	EGFR inhibitor|ErbB2 inhibitor	EGFR|ERBB2	Harris2016; 24h > 120h in Pr500 pilot	C-5001-01-LM6-031	lapatinib	lapatinib:1.111 uM
F04	BRD-K19687926	lapatinib	trt_cp	0.37 uM	BRD-K19687926-001-13-2	lapatinib	0.37037	uM	DMSO	PGR001	EGFR inhibitor|ErbB2 inhibitor	EGFR|ERBB2	Harris2016; 24h > 120h in Pr500 pilot	C-5001-01-LM6-031	lapatinib	lapatinib:0.37 uM
F05	BRD-K19687926	lapatinib	trt_cp	0.123 uM	BRD-K19687926-001-13-2	lapatinib	0.123457	uM	DMSO	PGR001	EGFR inhibitor|ErbB2 inhibitor	EGFR|ERBB2	Harris2016; 24h > 120h in Pr500 pilot	C-5001-01-LM6-031	lapatinib	lapatinib:0.123 uM
F06	BRD-K19687926	lapatinib	trt_cp	0.041 uM	BRD-K19687926-001-13-2	lapatinib	0.0411523	uM	DMSO	PGR001	EGFR inhibitor|ErbB2 inhibitor	EGFR|ERBB2	Harris2016; 24h > 120h in Pr500 pilot	C-5001-01-LM6-031	lapatinib	lapatinib:0.041 uM
F07	BRD-K78431006	crizotinib	trt_cp	10.0 uM	BRD-K78431006-001-01-1	crizotinib	10	uM	DMSO	PGR001	ALK tyrosine kinase receptor inhibitor	ALK|MET	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	crizotinib	crizotinib:10.0 uM
F08	BRD-K78431006	crizotinib	trt_cp	3.333 uM	BRD-K78431006-001-01-1	crizotinib	3.33333	uM	DMSO	PGR001	ALK tyrosine kinase receptor inhibitor	ALK|MET	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	crizotinib	crizotinib:3.333 uM
F09	BRD-K78431006	crizotinib	trt_cp	1.111 uM	BRD-K78431006-001-01-1	crizotinib	1.11111	uM	DMSO	PGR001	ALK tyrosine kinase receptor inhibitor	ALK|MET	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	crizotinib	crizotinib:1.111 uM
F10	BRD-K78431006	crizotinib	trt_cp	0.37 uM	BRD-K78431006-001-01-1	crizotinib	0.37037	uM	DMSO	PGR001	ALK tyrosine kinase receptor inhibitor	ALK|MET	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	crizotinib	crizotinib:0.37 uM
F11	BRD-K78431006	crizotinib	trt_cp	0.123 uM	BRD-K78431006-001-01-1	crizotinib	0.123457	uM	DMSO	PGR001	ALK tyrosine kinase receptor inhibitor	ALK|MET	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	crizotinib	crizotinib:0.123 uM
F12	BRD-K78431006	crizotinib	trt_cp	0.041 uM	BRD-K78431006-001-01-1	crizotinib	0.0411523	uM	DMSO	PGR001	ALK tyrosine kinase receptor inhibitor	ALK|MET	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	crizotinib	crizotinib:0.041 uM
F13	BRD-K66175015	afatinib	trt_cp	10.0 uM	BRD-K66175015-001-01-7	afatinib	10	uM	DMSO	PGR001	EGFR inhibitor	EGFR|ERBB2|ERBB4	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	afatinib	afatinib:10.0 uM
F14	BRD-K66175015	afatinib	trt_cp	3.333 uM	BRD-K66175015-001-01-7	afatinib	3.33333	uM	DMSO	PGR001	EGFR inhibitor	EGFR|ERBB2|ERBB4	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	afatinib	afatinib:3.333 uM
F15	BRD-K66175015	afatinib	trt_cp	1.111 uM	BRD-K66175015-001-01-7	afatinib	1.11111	uM	DMSO	PGR001	EGFR inhibitor	EGFR|ERBB2|ERBB4	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	afatinib	afatinib:1.111 uM
F16	BRD-K66175015	afatinib	trt_cp	0.37 uM	BRD-K66175015-001-01-7	afatinib	0.37037	uM	DMSO	PGR001	EGFR inhibitor	EGFR|ERBB2|ERBB4	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	afatinib	afatinib:0.37 uM
F17	BRD-K66175015	afatinib	trt_cp	0.123 uM	BRD-K66175015-001-01-7	afatinib	0.123457	uM	DMSO	PGR001	EGFR inhibitor	EGFR|ERBB2|ERBB4	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	afatinib	afatinib:0.123 uM
F18	BRD-K66175015	afatinib	trt_cp	0.041 uM	BRD-K66175015-001-01-7	afatinib	0.0411523	uM	DMSO	PGR001	EGFR inhibitor	EGFR|ERBB2|ERBB4	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	afatinib	afatinib:0.041 uM
F19	BRD-A25004090	erastin	trt_cp	10.0 uM	BRD-A25004090-001-03-5	erastin	10	uM	DMSO	PGR001	Ion channel antagonist	VDAC2	Forcina2017	C-5001-01-LM6-031	erastin	erastin:10.0 uM
F20	BRD-A25004090	erastin	trt_cp	3.333 uM	BRD-A25004090-001-03-5	erastin	3.33333	uM	DMSO	PGR001	Ion channel antagonist	VDAC2	Forcina2017	C-5001-01-LM6-031	erastin	erastin:3.333 uM
F21	BRD-A25004090	erastin	trt_cp	1.111 uM	BRD-A25004090-001-03-5	erastin	1.11111	uM	DMSO	PGR001	Ion channel antagonist	VDAC2	Forcina2017	C-5001-01-LM6-031	erastin	erastin:1.111 uM
F22	BRD-A25004090	erastin	trt_cp	0.37 uM	BRD-A25004090-001-03-5	erastin	0.37037	uM	DMSO	PGR001	Ion channel antagonist	VDAC2	Forcina2017	C-5001-01-LM6-031	erastin	erastin:0.37 uM
F23	BRD-A25004090	erastin	trt_cp	0.123 uM	BRD-A25004090-001-03-5	erastin	0.123457	uM	DMSO	PGR001	Ion channel antagonist	VDAC2	Forcina2017	C-5001-01-LM6-031	erastin	erastin:0.123 uM
F24	BRD-A25004090	erastin	trt_cp	0.041 uM	BRD-A25004090-001-03-5	erastin	0.0411523	uM	DMSO	PGR001	Ion channel antagonist	VDAC2	Forcina2017	C-5001-01-LM6-031	erastin	erastin:0.041 uM
G01	BRD-K70401845	erlotinib	trt_cp	10.0 uM	BRD-K70401845-003-11-2	erlotinib	10	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.1	erlotinib.1:10.0 uM
G02	BRD-K70401845	erlotinib	trt_cp	3.333 uM	BRD-K70401845-003-11-2	erlotinib	3.33333	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.1	erlotinib.1:3.333 uM
G03	BRD-K70401845	erlotinib	trt_cp	1.111 uM	BRD-K70401845-003-11-2	erlotinib	1.11111	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.1	erlotinib.1:1.111 uM
G04	BRD-K70401845	erlotinib	trt_cp	0.37 uM	BRD-K70401845-003-11-2	erlotinib	0.37037	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.1	erlotinib.1:0.37 uM
G05	BRD-K70401845	erlotinib	trt_cp	0.123 uM	BRD-K70401845-003-11-2	erlotinib	0.123457	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.1	erlotinib.1:0.123 uM
G06	BRD-K70401845	erlotinib	trt_cp	0.041 uM	BRD-K70401845-003-11-2	erlotinib	0.0411523	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.1	erlotinib.1:0.041 uM
G07	BRD-K59146805	AZ-3146	trt_cp	10.0 uM	BRD-K59146805-001-07-8	AZ-3146	10	uM	DMSO	PGR001	Monopolar spindle 1 kinase inhibitor	-666	Forcina2017	C-5001-01-LM6-031	AZ-3146	AZ-3146:10.0 uM
G08	BRD-K59146805	AZ-3146	trt_cp	3.333 uM	BRD-K59146805-001-07-8	AZ-3146	3.33333	uM	DMSO	PGR001	Monopolar spindle 1 kinase inhibitor	-666	Forcina2017	C-5001-01-LM6-031	AZ-3146	AZ-3146:3.333 uM
G09	BRD-K59146805	AZ-3146	trt_cp	1.111 uM	BRD-K59146805-001-07-8	AZ-3146	1.11111	uM	DMSO	PGR001	Monopolar spindle 1 kinase inhibitor	-666	Forcina2017	C-5001-01-LM6-031	AZ-3146	AZ-3146:1.111 uM
G10	BRD-K59146805	AZ-3146	trt_cp	0.37 uM	BRD-K59146805-001-07-8	AZ-3146	0.37037	uM	DMSO	PGR001	Monopolar spindle 1 kinase inhibitor	-666	Forcina2017	C-5001-01-LM6-031	AZ-3146	AZ-3146:0.37 uM
G11	BRD-K59146805	AZ-3146	trt_cp	0.123 uM	BRD-K59146805-001-07-8	AZ-3146	0.123457	uM	DMSO	PGR001	Monopolar spindle 1 kinase inhibitor	-666	Forcina2017	C-5001-01-LM6-031	AZ-3146	AZ-3146:0.123 uM
G12	BRD-K59146805	AZ-3146	trt_cp	0.041 uM	BRD-K59146805-001-07-8	AZ-3146	0.0411523	uM	DMSO	PGR001	Monopolar spindle 1 kinase inhibitor	-666	Forcina2017	C-5001-01-LM6-031	AZ-3146	AZ-3146:0.041 uM
G13	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.01	DMSO.01:-666
G14	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.03	DMSO.03:-666
G15	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.01	DMSO.01:-666
G16	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.07	DMSO.07:-666
G17	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.06	DMSO.06:-666
G18	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.04	DMSO.04:-666
G19	BRD-K66175015	afatinib	trt_cp	10.0 uM	BRD-K66175015-001-01-7	afatinib	10	uM	DMSO	PGR001	EGFR inhibitor	EGFR|ERBB2|ERBB4	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	afatinib	afatinib:10.0 uM
G20	BRD-K66175015	afatinib	trt_cp	3.333 uM	BRD-K66175015-001-01-7	afatinib	3.33333	uM	DMSO	PGR001	EGFR inhibitor	EGFR|ERBB2|ERBB4	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	afatinib	afatinib:3.333 uM
G21	BRD-K66175015	afatinib	trt_cp	1.111 uM	BRD-K66175015-001-01-7	afatinib	1.11111	uM	DMSO	PGR001	EGFR inhibitor	EGFR|ERBB2|ERBB4	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	afatinib	afatinib:1.111 uM
G22	BRD-K66175015	afatinib	trt_cp	0.37 uM	BRD-K66175015-001-01-7	afatinib	0.37037	uM	DMSO	PGR001	EGFR inhibitor	EGFR|ERBB2|ERBB4	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	afatinib	afatinib:0.37 uM
G23	BRD-K66175015	afatinib	trt_cp	0.123 uM	BRD-K66175015-001-01-7	afatinib	0.123457	uM	DMSO	PGR001	EGFR inhibitor	EGFR|ERBB2|ERBB4	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	afatinib	afatinib:0.123 uM
G24	BRD-K66175015	afatinib	trt_cp	0.041 uM	BRD-K66175015-001-01-7	afatinib	0.0411523	uM	DMSO	PGR001	EGFR inhibitor	EGFR|ERBB2|ERBB4	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	afatinib	afatinib:0.041 uM
H01	BRD-K49865102	PD-0325901	trt_cp	10.0 uM	BRD-K49865102-001-14-2	PD-0325901	10	uM	DMSO	PGR001	MAP kinase inhibitor|Protein kinase inhibitor|MEK inhibitor	MAP2K1	Chan2013	C-5001-01-LM6-031	PD-0325901	PD-0325901:10.0 uM
H02	BRD-K49865102	PD-0325901	trt_cp	3.333 uM	BRD-K49865102-001-14-2	PD-0325901	3.33333	uM	DMSO	PGR001	MAP kinase inhibitor|Protein kinase inhibitor|MEK inhibitor	MAP2K1	Chan2013	C-5001-01-LM6-031	PD-0325901	PD-0325901:3.333 uM
H03	BRD-K49865102	PD-0325901	trt_cp	1.111 uM	BRD-K49865102-001-14-2	PD-0325901	1.11111	uM	DMSO	PGR001	MAP kinase inhibitor|Protein kinase inhibitor|MEK inhibitor	MAP2K1	Chan2013	C-5001-01-LM6-031	PD-0325901	PD-0325901:1.111 uM
H04	BRD-K49865102	PD-0325901	trt_cp	0.37 uM	BRD-K49865102-001-14-2	PD-0325901	0.37037	uM	DMSO	PGR001	MAP kinase inhibitor|Protein kinase inhibitor|MEK inhibitor	MAP2K1	Chan2013	C-5001-01-LM6-031	PD-0325901	PD-0325901:0.37 uM
H05	BRD-K49865102	PD-0325901	trt_cp	0.123 uM	BRD-K49865102-001-14-2	PD-0325901	0.123457	uM	DMSO	PGR001	MAP kinase inhibitor|Protein kinase inhibitor|MEK inhibitor	MAP2K1	Chan2013	C-5001-01-LM6-031	PD-0325901	PD-0325901:0.123 uM
H06	BRD-K49865102	PD-0325901	trt_cp	0.041 uM	BRD-K49865102-001-14-2	PD-0325901	0.0411523	uM	DMSO	PGR001	MAP kinase inhibitor|Protein kinase inhibitor|MEK inhibitor	MAP2K1	Chan2013	C-5001-01-LM6-031	PD-0325901	PD-0325901:0.041 uM
H07	BRD-K66175015	afatinib	trt_cp	10.0 uM	BRD-K66175015-001-01-7	afatinib	10	uM	DMSO	PGR001	EGFR inhibitor	EGFR|ERBB2|ERBB4	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	afatinib	afatinib:10.0 uM
H08	BRD-K66175015	afatinib	trt_cp	3.333 uM	BRD-K66175015-001-01-7	afatinib	3.33333	uM	DMSO	PGR001	EGFR inhibitor	EGFR|ERBB2|ERBB4	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	afatinib	afatinib:3.333 uM
H09	BRD-K66175015	afatinib	trt_cp	1.111 uM	BRD-K66175015-001-01-7	afatinib	1.11111	uM	DMSO	PGR001	EGFR inhibitor	EGFR|ERBB2|ERBB4	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	afatinib	afatinib:1.111 uM
H10	BRD-K66175015	afatinib	trt_cp	0.37 uM	BRD-K66175015-001-01-7	afatinib	0.37037	uM	DMSO	PGR001	EGFR inhibitor	EGFR|ERBB2|ERBB4	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	afatinib	afatinib:0.37 uM
H11	BRD-K66175015	afatinib	trt_cp	0.123 uM	BRD-K66175015-001-01-7	afatinib	0.123457	uM	DMSO	PGR001	EGFR inhibitor	EGFR|ERBB2|ERBB4	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	afatinib	afatinib:0.123 uM
H12	BRD-K66175015	afatinib	trt_cp	0.041 uM	BRD-K66175015-001-01-7	afatinib	0.0411523	uM	DMSO	PGR001	EGFR inhibitor	EGFR|ERBB2|ERBB4	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	afatinib	afatinib:0.041 uM
H13	BRD-K49865102	PD-0325901	trt_cp	10.0 uM	BRD-K49865102-001-14-2	PD-0325901	10	uM	DMSO	PGR001	MAP kinase inhibitor|Protein kinase inhibitor|MEK inhibitor	MAP2K1	Chan2013	C-5001-01-LM6-031	PD-0325901	PD-0325901:10.0 uM
H14	BRD-K49865102	PD-0325901	trt_cp	3.333 uM	BRD-K49865102-001-14-2	PD-0325901	3.33333	uM	DMSO	PGR001	MAP kinase inhibitor|Protein kinase inhibitor|MEK inhibitor	MAP2K1	Chan2013	C-5001-01-LM6-031	PD-0325901	PD-0325901:3.333 uM
H15	BRD-K49865102	PD-0325901	trt_cp	1.111 uM	BRD-K49865102-001-14-2	PD-0325901	1.11111	uM	DMSO	PGR001	MAP kinase inhibitor|Protein kinase inhibitor|MEK inhibitor	MAP2K1	Chan2013	C-5001-01-LM6-031	PD-0325901	PD-0325901:1.111 uM
H16	BRD-K49865102	PD-0325901	trt_cp	0.37 uM	BRD-K49865102-001-14-2	PD-0325901	0.37037	uM	DMSO	PGR001	MAP kinase inhibitor|Protein kinase inhibitor|MEK inhibitor	MAP2K1	Chan2013	C-5001-01-LM6-031	PD-0325901	PD-0325901:0.37 uM
H17	BRD-K49865102	PD-0325901	trt_cp	0.123 uM	BRD-K49865102-001-14-2	PD-0325901	0.123457	uM	DMSO	PGR001	MAP kinase inhibitor|Protein kinase inhibitor|MEK inhibitor	MAP2K1	Chan2013	C-5001-01-LM6-031	PD-0325901	PD-0325901:0.123 uM
H18	BRD-K49865102	PD-0325901	trt_cp	0.041 uM	BRD-K49865102-001-14-2	PD-0325901	0.0411523	uM	DMSO	PGR001	MAP kinase inhibitor|Protein kinase inhibitor|MEK inhibitor	MAP2K1	Chan2013	C-5001-01-LM6-031	PD-0325901	PD-0325901:0.041 uM
H19	BRD-K37890730	camptothecin	trt_cp	10.0 uM	BRD-K37890730-001-21-9	camptothecin	10	uM	DMSO	PGR001	Topoisomerase inhibitor	TOP1	Forcina2017	C-5001-01-LM6-031	camptothecin	camptothecin:10.0 uM
H20	BRD-K37890730	camptothecin	trt_cp	3.333 uM	BRD-K37890730-001-21-9	camptothecin	3.33333	uM	DMSO	PGR001	Topoisomerase inhibitor	TOP1	Forcina2017	C-5001-01-LM6-031	camptothecin	camptothecin:3.333 uM
H21	BRD-K37890730	camptothecin	trt_cp	1.111 uM	BRD-K37890730-001-21-9	camptothecin	1.11111	uM	DMSO	PGR001	Topoisomerase inhibitor	TOP1	Forcina2017	C-5001-01-LM6-031	camptothecin	camptothecin:1.111 uM
H22	BRD-K37890730	camptothecin	trt_cp	0.37 uM	BRD-K37890730-001-21-9	camptothecin	0.37037	uM	DMSO	PGR001	Topoisomerase inhibitor	TOP1	Forcina2017	C-5001-01-LM6-031	camptothecin	camptothecin:0.37 uM
H23	BRD-K37890730	camptothecin	trt_cp	0.123 uM	BRD-K37890730-001-21-9	camptothecin	0.123457	uM	DMSO	PGR001	Topoisomerase inhibitor	TOP1	Forcina2017	C-5001-01-LM6-031	camptothecin	camptothecin:0.123 uM
H24	BRD-K37890730	camptothecin	trt_cp	0.041 uM	BRD-K37890730-001-21-9	camptothecin	0.0411523	uM	DMSO	PGR001	Topoisomerase inhibitor	TOP1	Forcina2017	C-5001-01-LM6-031	camptothecin	camptothecin:0.041 uM
I01	BRD-K59369769	tozasertib	trt_cp	10.0 uM	BRD-K59369769-001-05-4	tozasertib	10	uM	DMSO	PGR001	Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor	ABL1|AURKA|AURKB|AURKC|BCR|FLT3|JAK2	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	tozasertib	tozasertib:10.0 uM
I02	BRD-K59369769	tozasertib	trt_cp	3.333 uM	BRD-K59369769-001-05-4	tozasertib	3.33333	uM	DMSO	PGR001	Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor	ABL1|AURKA|AURKB|AURKC|BCR|FLT3|JAK2	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	tozasertib	tozasertib:3.333 uM
I03	BRD-K59369769	tozasertib	trt_cp	1.111 uM	BRD-K59369769-001-05-4	tozasertib	1.11111	uM	DMSO	PGR001	Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor	ABL1|AURKA|AURKB|AURKC|BCR|FLT3|JAK2	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	tozasertib	tozasertib:1.111 uM
I04	BRD-K59369769	tozasertib	trt_cp	0.37 uM	BRD-K59369769-001-05-4	tozasertib	0.37037	uM	DMSO	PGR001	Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor	ABL1|AURKA|AURKB|AURKC|BCR|FLT3|JAK2	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	tozasertib	tozasertib:0.37 uM
I05	BRD-K59369769	tozasertib	trt_cp	0.123 uM	BRD-K59369769-001-05-4	tozasertib	0.123457	uM	DMSO	PGR001	Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor	ABL1|AURKA|AURKB|AURKC|BCR|FLT3|JAK2	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	tozasertib	tozasertib:0.123 uM
I06	BRD-K59369769	tozasertib	trt_cp	0.041 uM	BRD-K59369769-001-05-4	tozasertib	0.0411523	uM	DMSO	PGR001	Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor	ABL1|AURKA|AURKB|AURKC|BCR|FLT3|JAK2	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	tozasertib	tozasertib:0.041 uM
I07	BRD-K59146805	AZ-3146	trt_cp	10.0 uM	BRD-K59146805-001-07-8	AZ-3146	10	uM	DMSO	PGR001	Monopolar spindle 1 kinase inhibitor	-666	Forcina2017	C-5001-01-LM6-031	AZ-3146	AZ-3146:10.0 uM
I08	BRD-K59146805	AZ-3146	trt_cp	3.333 uM	BRD-K59146805-001-07-8	AZ-3146	3.33333	uM	DMSO	PGR001	Monopolar spindle 1 kinase inhibitor	-666	Forcina2017	C-5001-01-LM6-031	AZ-3146	AZ-3146:3.333 uM
I09	BRD-K59146805	AZ-3146	trt_cp	1.111 uM	BRD-K59146805-001-07-8	AZ-3146	1.11111	uM	DMSO	PGR001	Monopolar spindle 1 kinase inhibitor	-666	Forcina2017	C-5001-01-LM6-031	AZ-3146	AZ-3146:1.111 uM
I10	BRD-K59146805	AZ-3146	trt_cp	0.37 uM	BRD-K59146805-001-07-8	AZ-3146	0.37037	uM	DMSO	PGR001	Monopolar spindle 1 kinase inhibitor	-666	Forcina2017	C-5001-01-LM6-031	AZ-3146	AZ-3146:0.37 uM
I11	BRD-K59146805	AZ-3146	trt_cp	0.123 uM	BRD-K59146805-001-07-8	AZ-3146	0.123457	uM	DMSO	PGR001	Monopolar spindle 1 kinase inhibitor	-666	Forcina2017	C-5001-01-LM6-031	AZ-3146	AZ-3146:0.123 uM
I12	BRD-K59146805	AZ-3146	trt_cp	0.041 uM	BRD-K59146805-001-07-8	AZ-3146	0.0411523	uM	DMSO	PGR001	Monopolar spindle 1 kinase inhibitor	-666	Forcina2017	C-5001-01-LM6-031	AZ-3146	AZ-3146:0.041 uM
I13	BRD-K29415052	BGT-226	trt_cp	10.0 uM	BRD-K29415052-001-01-7	BGT-226	10	uM	DMSO	PGR001	PI3K inhibitor	-666	Forcina2017	C-5001-01-LM6-031	BGT-226	BGT-226:10.0 uM
I14	BRD-K29415052	BGT-226	trt_cp	3.333 uM	BRD-K29415052-001-01-7	BGT-226	3.33333	uM	DMSO	PGR001	PI3K inhibitor	-666	Forcina2017	C-5001-01-LM6-031	BGT-226	BGT-226:3.333 uM
I15	BRD-K29415052	BGT-226	trt_cp	1.111 uM	BRD-K29415052-001-01-7	BGT-226	1.11111	uM	DMSO	PGR001	PI3K inhibitor	-666	Forcina2017	C-5001-01-LM6-031	BGT-226	BGT-226:1.111 uM
I16	BRD-K29415052	BGT-226	trt_cp	0.37 uM	BRD-K29415052-001-01-7	BGT-226	0.37037	uM	DMSO	PGR001	PI3K inhibitor	-666	Forcina2017	C-5001-01-LM6-031	BGT-226	BGT-226:0.37 uM
I17	BRD-K29415052	BGT-226	trt_cp	0.123 uM	BRD-K29415052-001-01-7	BGT-226	0.123457	uM	DMSO	PGR001	PI3K inhibitor	-666	Forcina2017	C-5001-01-LM6-031	BGT-226	BGT-226:0.123 uM
I18	BRD-K29415052	BGT-226	trt_cp	0.041 uM	BRD-K29415052-001-01-7	BGT-226	0.0411523	uM	DMSO	PGR001	PI3K inhibitor	-666	Forcina2017	C-5001-01-LM6-031	BGT-226	BGT-226:0.041 uM
I19	BRD-A63610676	paclitaxel	trt_cp	10.0 uM	BRD-A63610676-001-15-8	paclitaxel	10	uM	DMSO	PGR001	Tubulin inhibitor	NR1I2|TUBB	Chan2013	C-5001-01-LM6-031	paclitaxel	paclitaxel:10.0 uM
I20	BRD-A63610676	paclitaxel	trt_cp	3.333 uM	BRD-A63610676-001-15-8	paclitaxel	3.33333	uM	DMSO	PGR001	Tubulin inhibitor	NR1I2|TUBB	Chan2013	C-5001-01-LM6-031	paclitaxel	paclitaxel:3.333 uM
I21	BRD-A63610676	paclitaxel	trt_cp	1.111 uM	BRD-A63610676-001-15-8	paclitaxel	1.11111	uM	DMSO	PGR001	Tubulin inhibitor	NR1I2|TUBB	Chan2013	C-5001-01-LM6-031	paclitaxel	paclitaxel:1.111 uM
I22	BRD-A63610676	paclitaxel	trt_cp	0.37 uM	BRD-A63610676-001-15-8	paclitaxel	0.37037	uM	DMSO	PGR001	Tubulin inhibitor	NR1I2|TUBB	Chan2013	C-5001-01-LM6-031	paclitaxel	paclitaxel:0.37 uM
I23	BRD-A63610676	paclitaxel	trt_cp	0.123 uM	BRD-A63610676-001-15-8	paclitaxel	0.123457	uM	DMSO	PGR001	Tubulin inhibitor	NR1I2|TUBB	Chan2013	C-5001-01-LM6-031	paclitaxel	paclitaxel:0.123 uM
I24	BRD-A63610676	paclitaxel	trt_cp	0.041 uM	BRD-A63610676-001-15-8	paclitaxel	0.0411523	uM	DMSO	PGR001	Tubulin inhibitor	NR1I2|TUBB	Chan2013	C-5001-01-LM6-031	paclitaxel	paclitaxel:0.041 uM
J01	BRD-K15616905	CCCP	trt_cp	10.0 uM	BRD-K15616905-001-03-1	CCCP	10	uM	DMSO	PGR001	Mitochondrial oxidative phosphorylation uncoupler	-666	Forcina2017	C-5001-01-LM6-031	CCCP	CCCP:10.0 uM
J02	BRD-K15616905	CCCP	trt_cp	3.333 uM	BRD-K15616905-001-03-1	CCCP	3.33333	uM	DMSO	PGR001	Mitochondrial oxidative phosphorylation uncoupler	-666	Forcina2017	C-5001-01-LM6-031	CCCP	CCCP:3.333 uM
J03	BRD-K15616905	CCCP	trt_cp	1.111 uM	BRD-K15616905-001-03-1	CCCP	1.11111	uM	DMSO	PGR001	Mitochondrial oxidative phosphorylation uncoupler	-666	Forcina2017	C-5001-01-LM6-031	CCCP	CCCP:1.111 uM
J04	BRD-K15616905	CCCP	trt_cp	0.37 uM	BRD-K15616905-001-03-1	CCCP	0.37037	uM	DMSO	PGR001	Mitochondrial oxidative phosphorylation uncoupler	-666	Forcina2017	C-5001-01-LM6-031	CCCP	CCCP:0.37 uM
J05	BRD-K15616905	CCCP	trt_cp	0.123 uM	BRD-K15616905-001-03-1	CCCP	0.123457	uM	DMSO	PGR001	Mitochondrial oxidative phosphorylation uncoupler	-666	Forcina2017	C-5001-01-LM6-031	CCCP	CCCP:0.123 uM
J06	BRD-K15616905	CCCP	trt_cp	0.041 uM	BRD-K15616905-001-03-1	CCCP	0.0411523	uM	DMSO	PGR001	Mitochondrial oxidative phosphorylation uncoupler	-666	Forcina2017	C-5001-01-LM6-031	CCCP	CCCP:0.041 uM
J07	BRD-K16478699	PLX-4720	trt_cp	10.0 uM	BRD-K16478699-001-01-9	PLX-4720	10	uM	DMSO	PGR001	RAF inhibitor	BRAF	Hafner2016; Harris et al	C-5001-01-LM6-031	PLX-4720	PLX-4720:10.0 uM
J08	BRD-K16478699	PLX-4720	trt_cp	3.333 uM	BRD-K16478699-001-01-9	PLX-4720	3.33333	uM	DMSO	PGR001	RAF inhibitor	BRAF	Hafner2016; Harris et al	C-5001-01-LM6-031	PLX-4720	PLX-4720:3.333 uM
J09	BRD-K16478699	PLX-4720	trt_cp	1.111 uM	BRD-K16478699-001-01-9	PLX-4720	1.11111	uM	DMSO	PGR001	RAF inhibitor	BRAF	Hafner2016; Harris et al	C-5001-01-LM6-031	PLX-4720	PLX-4720:1.111 uM
J10	BRD-K16478699	PLX-4720	trt_cp	0.37 uM	BRD-K16478699-001-01-9	PLX-4720	0.37037	uM	DMSO	PGR001	RAF inhibitor	BRAF	Hafner2016; Harris et al	C-5001-01-LM6-031	PLX-4720	PLX-4720:0.37 uM
J11	BRD-K16478699	PLX-4720	trt_cp	0.123 uM	BRD-K16478699-001-01-9	PLX-4720	0.123457	uM	DMSO	PGR001	RAF inhibitor	BRAF	Hafner2016; Harris et al	C-5001-01-LM6-031	PLX-4720	PLX-4720:0.123 uM
J12	BRD-K16478699	PLX-4720	trt_cp	0.041 uM	BRD-K16478699-001-01-9	PLX-4720	0.0411523	uM	DMSO	PGR001	RAF inhibitor	BRAF	Hafner2016; Harris et al	C-5001-01-LM6-031	PLX-4720	PLX-4720:0.041 uM
J13	BRD-K19687926	lapatinib	trt_cp	10.0 uM	BRD-K19687926-001-13-2	lapatinib	10	uM	DMSO	PGR001	EGFR inhibitor|ErbB2 inhibitor	EGFR|ERBB2	Harris2016; 24h > 120h in Pr500 pilot	C-5001-01-LM6-031	lapatinib	lapatinib:10.0 uM
J14	BRD-K19687926	lapatinib	trt_cp	3.333 uM	BRD-K19687926-001-13-2	lapatinib	3.33333	uM	DMSO	PGR001	EGFR inhibitor|ErbB2 inhibitor	EGFR|ERBB2	Harris2016; 24h > 120h in Pr500 pilot	C-5001-01-LM6-031	lapatinib	lapatinib:3.333 uM
J15	BRD-K19687926	lapatinib	trt_cp	1.111 uM	BRD-K19687926-001-13-2	lapatinib	1.11111	uM	DMSO	PGR001	EGFR inhibitor|ErbB2 inhibitor	EGFR|ERBB2	Harris2016; 24h > 120h in Pr500 pilot	C-5001-01-LM6-031	lapatinib	lapatinib:1.111 uM
J16	BRD-K19687926	lapatinib	trt_cp	0.37 uM	BRD-K19687926-001-13-2	lapatinib	0.37037	uM	DMSO	PGR001	EGFR inhibitor|ErbB2 inhibitor	EGFR|ERBB2	Harris2016; 24h > 120h in Pr500 pilot	C-5001-01-LM6-031	lapatinib	lapatinib:0.37 uM
J17	BRD-K19687926	lapatinib	trt_cp	0.123 uM	BRD-K19687926-001-13-2	lapatinib	0.123457	uM	DMSO	PGR001	EGFR inhibitor|ErbB2 inhibitor	EGFR|ERBB2	Harris2016; 24h > 120h in Pr500 pilot	C-5001-01-LM6-031	lapatinib	lapatinib:0.123 uM
J18	BRD-K19687926	lapatinib	trt_cp	0.041 uM	BRD-K19687926-001-13-2	lapatinib	0.0411523	uM	DMSO	PGR001	EGFR inhibitor|ErbB2 inhibitor	EGFR|ERBB2	Harris2016; 24h > 120h in Pr500 pilot	C-5001-01-LM6-031	lapatinib	lapatinib:0.041 uM
J19	BRD-K51544265	cabozantinib	trt_cp	10.0 uM	BRD-K51544265-001-10-9	cabozantinib	10	uM	DMSO	PGR001	RET tyrosine kinase inhibitor|VEGFR inhibitor	KDR|MET|FLT3|KIT|RET|TEK	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	cabozantinib	cabozantinib:10.0 uM
J20	BRD-K51544265	cabozantinib	trt_cp	3.333 uM	BRD-K51544265-001-10-9	cabozantinib	3.33333	uM	DMSO	PGR001	RET tyrosine kinase inhibitor|VEGFR inhibitor	KDR|MET|FLT3|KIT|RET|TEK	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	cabozantinib	cabozantinib:3.333 uM
J21	BRD-K51544265	cabozantinib	trt_cp	1.111 uM	BRD-K51544265-001-10-9	cabozantinib	1.11111	uM	DMSO	PGR001	RET tyrosine kinase inhibitor|VEGFR inhibitor	KDR|MET|FLT3|KIT|RET|TEK	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	cabozantinib	cabozantinib:1.111 uM
J22	BRD-K51544265	cabozantinib	trt_cp	0.37 uM	BRD-K51544265-001-10-9	cabozantinib	0.37037	uM	DMSO	PGR001	RET tyrosine kinase inhibitor|VEGFR inhibitor	KDR|MET|FLT3|KIT|RET|TEK	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	cabozantinib	cabozantinib:0.37 uM
J23	BRD-K51544265	cabozantinib	trt_cp	0.123 uM	BRD-K51544265-001-10-9	cabozantinib	0.123457	uM	DMSO	PGR001	RET tyrosine kinase inhibitor|VEGFR inhibitor	KDR|MET|FLT3|KIT|RET|TEK	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	cabozantinib	cabozantinib:0.123 uM
J24	BRD-K51544265	cabozantinib	trt_cp	0.041 uM	BRD-K51544265-001-10-9	cabozantinib	0.0411523	uM	DMSO	PGR001	RET tyrosine kinase inhibitor|VEGFR inhibitor	KDR|MET|FLT3|KIT|RET|TEK	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	cabozantinib	cabozantinib:0.041 uM
K01	BRD-K86118762	linsitinib	trt_cp	10.0 uM	BRD-K86118762-001-07-5	linsitinib	10	uM	DMSO	PGR001	IGF-1 inhibitor	IGF1R|INSR	Hafner2016	C-5001-01-LM6-031	linsitinib	linsitinib:10.0 uM
K02	BRD-K86118762	linsitinib	trt_cp	3.333 uM	BRD-K86118762-001-07-5	linsitinib	3.33333	uM	DMSO	PGR001	IGF-1 inhibitor	IGF1R|INSR	Hafner2016	C-5001-01-LM6-031	linsitinib	linsitinib:3.333 uM
K03	BRD-K86118762	linsitinib	trt_cp	1.111 uM	BRD-K86118762-001-07-5	linsitinib	1.11111	uM	DMSO	PGR001	IGF-1 inhibitor	IGF1R|INSR	Hafner2016	C-5001-01-LM6-031	linsitinib	linsitinib:1.111 uM
K04	BRD-K86118762	linsitinib	trt_cp	0.37 uM	BRD-K86118762-001-07-5	linsitinib	0.37037	uM	DMSO	PGR001	IGF-1 inhibitor	IGF1R|INSR	Hafner2016	C-5001-01-LM6-031	linsitinib	linsitinib:0.37 uM
K05	BRD-K86118762	linsitinib	trt_cp	0.123 uM	BRD-K86118762-001-07-5	linsitinib	0.123457	uM	DMSO	PGR001	IGF-1 inhibitor	IGF1R|INSR	Hafner2016	C-5001-01-LM6-031	linsitinib	linsitinib:0.123 uM
K06	BRD-K86118762	linsitinib	trt_cp	0.041 uM	BRD-K86118762-001-07-5	linsitinib	0.0411523	uM	DMSO	PGR001	IGF-1 inhibitor	IGF1R|INSR	Hafner2016	C-5001-01-LM6-031	linsitinib	linsitinib:0.041 uM
K07	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.05	DMSO.05:-666
K08	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.03	DMSO.03:-666
K09	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.09	DMSO.09:-666
K10	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.07	DMSO.07:-666
K11	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.01	DMSO.01:-666
K12	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.05	DMSO.05:-666
K13	BRD-K78431006	crizotinib	trt_cp	10.0 uM	BRD-K78431006-001-01-1	crizotinib	10	uM	DMSO	PGR001	ALK tyrosine kinase receptor inhibitor	ALK|MET	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	crizotinib	crizotinib:10.0 uM
K14	BRD-K78431006	crizotinib	trt_cp	3.333 uM	BRD-K78431006-001-01-1	crizotinib	3.33333	uM	DMSO	PGR001	ALK tyrosine kinase receptor inhibitor	ALK|MET	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	crizotinib	crizotinib:3.333 uM
K15	BRD-K78431006	crizotinib	trt_cp	1.111 uM	BRD-K78431006-001-01-1	crizotinib	1.11111	uM	DMSO	PGR001	ALK tyrosine kinase receptor inhibitor	ALK|MET	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	crizotinib	crizotinib:1.111 uM
K16	BRD-K78431006	crizotinib	trt_cp	0.37 uM	BRD-K78431006-001-01-1	crizotinib	0.37037	uM	DMSO	PGR001	ALK tyrosine kinase receptor inhibitor	ALK|MET	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	crizotinib	crizotinib:0.37 uM
K17	BRD-K78431006	crizotinib	trt_cp	0.123 uM	BRD-K78431006-001-01-1	crizotinib	0.123457	uM	DMSO	PGR001	ALK tyrosine kinase receptor inhibitor	ALK|MET	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	crizotinib	crizotinib:0.123 uM
K18	BRD-K78431006	crizotinib	trt_cp	0.041 uM	BRD-K78431006-001-01-1	crizotinib	0.0411523	uM	DMSO	PGR001	ALK tyrosine kinase receptor inhibitor	ALK|MET	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	crizotinib	crizotinib:0.041 uM
K19	BRD-K86118762	linsitinib	trt_cp	10.0 uM	BRD-K86118762-001-07-5	linsitinib	10	uM	DMSO	PGR001	IGF-1 inhibitor	IGF1R|INSR	Hafner2016	C-5001-01-LM6-031	linsitinib	linsitinib:10.0 uM
K20	BRD-K86118762	linsitinib	trt_cp	3.333 uM	BRD-K86118762-001-07-5	linsitinib	3.33333	uM	DMSO	PGR001	IGF-1 inhibitor	IGF1R|INSR	Hafner2016	C-5001-01-LM6-031	linsitinib	linsitinib:3.333 uM
K21	BRD-K86118762	linsitinib	trt_cp	1.111 uM	BRD-K86118762-001-07-5	linsitinib	1.11111	uM	DMSO	PGR001	IGF-1 inhibitor	IGF1R|INSR	Hafner2016	C-5001-01-LM6-031	linsitinib	linsitinib:1.111 uM
K22	BRD-K86118762	linsitinib	trt_cp	0.37 uM	BRD-K86118762-001-07-5	linsitinib	0.37037	uM	DMSO	PGR001	IGF-1 inhibitor	IGF1R|INSR	Hafner2016	C-5001-01-LM6-031	linsitinib	linsitinib:0.37 uM
K23	BRD-K86118762	linsitinib	trt_cp	0.123 uM	BRD-K86118762-001-07-5	linsitinib	0.123457	uM	DMSO	PGR001	IGF-1 inhibitor	IGF1R|INSR	Hafner2016	C-5001-01-LM6-031	linsitinib	linsitinib:0.123 uM
K24	BRD-K86118762	linsitinib	trt_cp	0.041 uM	BRD-K86118762-001-07-5	linsitinib	0.0411523	uM	DMSO	PGR001	IGF-1 inhibitor	IGF1R|INSR	Hafner2016	C-5001-01-LM6-031	linsitinib	linsitinib:0.041 uM
L01	BRD-K08316444	rotenone	trt_cp	10.0 uM	BRD-K08316444-001-03-5	rotenone	10	uM	DMSO	PGR001	Mitochondrial complex I inhibitor	MT-ND1	Harris2016	C-5001-01-LM6-031	rotenone	rotenone:10.0 uM
L02	BRD-K08316444	rotenone	trt_cp	3.333 uM	BRD-K08316444-001-03-5	rotenone	3.33333	uM	DMSO	PGR001	Mitochondrial complex I inhibitor	MT-ND1	Harris2016	C-5001-01-LM6-031	rotenone	rotenone:3.333 uM
L03	BRD-K08316444	rotenone	trt_cp	1.111 uM	BRD-K08316444-001-03-5	rotenone	1.11111	uM	DMSO	PGR001	Mitochondrial complex I inhibitor	MT-ND1	Harris2016	C-5001-01-LM6-031	rotenone	rotenone:1.111 uM
L04	BRD-K08316444	rotenone	trt_cp	0.37 uM	BRD-K08316444-001-03-5	rotenone	0.37037	uM	DMSO	PGR001	Mitochondrial complex I inhibitor	MT-ND1	Harris2016	C-5001-01-LM6-031	rotenone	rotenone:0.37 uM
L05	BRD-K08316444	rotenone	trt_cp	0.123 uM	BRD-K08316444-001-03-5	rotenone	0.123457	uM	DMSO	PGR001	Mitochondrial complex I inhibitor	MT-ND1	Harris2016	C-5001-01-LM6-031	rotenone	rotenone:0.123 uM
L06	BRD-K08316444	rotenone	trt_cp	0.041 uM	BRD-K08316444-001-03-5	rotenone	0.0411523	uM	DMSO	PGR001	Mitochondrial complex I inhibitor	MT-ND1	Harris2016	C-5001-01-LM6-031	rotenone	rotenone:0.041 uM
L07	BRD-K59146805	AZ-3146	trt_cp	10.0 uM	BRD-K59146805-001-07-8	AZ-3146	10	uM	DMSO	PGR001	Monopolar spindle 1 kinase inhibitor	-666	Forcina2017	C-5001-01-LM6-031	AZ-3146	AZ-3146:10.0 uM
L08	BRD-K59146805	AZ-3146	trt_cp	3.333 uM	BRD-K59146805-001-07-8	AZ-3146	3.33333	uM	DMSO	PGR001	Monopolar spindle 1 kinase inhibitor	-666	Forcina2017	C-5001-01-LM6-031	AZ-3146	AZ-3146:3.333 uM
L09	BRD-K59146805	AZ-3146	trt_cp	1.111 uM	BRD-K59146805-001-07-8	AZ-3146	1.11111	uM	DMSO	PGR001	Monopolar spindle 1 kinase inhibitor	-666	Forcina2017	C-5001-01-LM6-031	AZ-3146	AZ-3146:1.111 uM
L10	BRD-K59146805	AZ-3146	trt_cp	0.37 uM	BRD-K59146805-001-07-8	AZ-3146	0.37037	uM	DMSO	PGR001	Monopolar spindle 1 kinase inhibitor	-666	Forcina2017	C-5001-01-LM6-031	AZ-3146	AZ-3146:0.37 uM
L11	BRD-K59146805	AZ-3146	trt_cp	0.123 uM	BRD-K59146805-001-07-8	AZ-3146	0.123457	uM	DMSO	PGR001	Monopolar spindle 1 kinase inhibitor	-666	Forcina2017	C-5001-01-LM6-031	AZ-3146	AZ-3146:0.123 uM
L12	BRD-K59146805	AZ-3146	trt_cp	0.041 uM	BRD-K59146805-001-07-8	AZ-3146	0.0411523	uM	DMSO	PGR001	Monopolar spindle 1 kinase inhibitor	-666	Forcina2017	C-5001-01-LM6-031	AZ-3146	AZ-3146:0.041 uM
L13	BRD-K78431006	crizotinib	trt_cp	10.0 uM	BRD-K78431006-001-01-1	crizotinib	10	uM	DMSO	PGR001	ALK tyrosine kinase receptor inhibitor	ALK|MET	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	crizotinib	crizotinib:10.0 uM
L14	BRD-K78431006	crizotinib	trt_cp	3.333 uM	BRD-K78431006-001-01-1	crizotinib	3.33333	uM	DMSO	PGR001	ALK tyrosine kinase receptor inhibitor	ALK|MET	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	crizotinib	crizotinib:3.333 uM
L15	BRD-K78431006	crizotinib	trt_cp	1.111 uM	BRD-K78431006-001-01-1	crizotinib	1.11111	uM	DMSO	PGR001	ALK tyrosine kinase receptor inhibitor	ALK|MET	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	crizotinib	crizotinib:1.111 uM
L16	BRD-K78431006	crizotinib	trt_cp	0.37 uM	BRD-K78431006-001-01-1	crizotinib	0.37037	uM	DMSO	PGR001	ALK tyrosine kinase receptor inhibitor	ALK|MET	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	crizotinib	crizotinib:0.37 uM
L17	BRD-K78431006	crizotinib	trt_cp	0.123 uM	BRD-K78431006-001-01-1	crizotinib	0.123457	uM	DMSO	PGR001	ALK tyrosine kinase receptor inhibitor	ALK|MET	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	crizotinib	crizotinib:0.123 uM
L18	BRD-K78431006	crizotinib	trt_cp	0.041 uM	BRD-K78431006-001-01-1	crizotinib	0.0411523	uM	DMSO	PGR001	ALK tyrosine kinase receptor inhibitor	ALK|MET	24h > 120h in Pr500 pilot	C-5001-01-LM6-031	crizotinib	crizotinib:0.041 uM
L19	BRD-K51544265	cabozantinib	trt_cp	10.0 uM	BRD-K51544265-001-10-9	cabozantinib	10	uM	DMSO	PGR001	RET tyrosine kinase inhibitor|VEGFR inhibitor	KDR|MET|FLT3|KIT|RET|TEK	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	cabozantinib	cabozantinib:10.0 uM
L20	BRD-K51544265	cabozantinib	trt_cp	3.333 uM	BRD-K51544265-001-10-9	cabozantinib	3.33333	uM	DMSO	PGR001	RET tyrosine kinase inhibitor|VEGFR inhibitor	KDR|MET|FLT3|KIT|RET|TEK	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	cabozantinib	cabozantinib:3.333 uM
L21	BRD-K51544265	cabozantinib	trt_cp	1.111 uM	BRD-K51544265-001-10-9	cabozantinib	1.11111	uM	DMSO	PGR001	RET tyrosine kinase inhibitor|VEGFR inhibitor	KDR|MET|FLT3|KIT|RET|TEK	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	cabozantinib	cabozantinib:1.111 uM
L22	BRD-K51544265	cabozantinib	trt_cp	0.37 uM	BRD-K51544265-001-10-9	cabozantinib	0.37037	uM	DMSO	PGR001	RET tyrosine kinase inhibitor|VEGFR inhibitor	KDR|MET|FLT3|KIT|RET|TEK	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	cabozantinib	cabozantinib:0.37 uM
L23	BRD-K51544265	cabozantinib	trt_cp	0.123 uM	BRD-K51544265-001-10-9	cabozantinib	0.123457	uM	DMSO	PGR001	RET tyrosine kinase inhibitor|VEGFR inhibitor	KDR|MET|FLT3|KIT|RET|TEK	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	cabozantinib	cabozantinib:0.123 uM
L24	BRD-K51544265	cabozantinib	trt_cp	0.041 uM	BRD-K51544265-001-10-9	cabozantinib	0.0411523	uM	DMSO	PGR001	RET tyrosine kinase inhibitor|VEGFR inhibitor	KDR|MET|FLT3|KIT|RET|TEK	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	cabozantinib	cabozantinib:0.041 uM
M01	BRD-K70401845	erlotinib	trt_cp	10.0 uM	BRD-K70401845-003-02-1	erlotinib	10	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.1	erlotinib.1:10.0 uM
M02	BRD-K70401845	erlotinib	trt_cp	3.333 uM	BRD-K70401845-003-02-1	erlotinib	3.33333	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.1	erlotinib.1:3.333 uM
M03	BRD-K70401845	erlotinib	trt_cp	1.111 uM	BRD-K70401845-003-02-1	erlotinib	1.11111	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.1	erlotinib.1:1.111 uM
M04	BRD-K70401845	erlotinib	trt_cp	0.37 uM	BRD-K70401845-003-02-1	erlotinib	0.37037	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.1	erlotinib.1:0.37 uM
M05	BRD-K70401845	erlotinib	trt_cp	0.123 uM	BRD-K70401845-003-02-1	erlotinib	0.123457	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.1	erlotinib.1:0.123 uM
M06	BRD-K70401845	erlotinib	trt_cp	0.041 uM	BRD-K70401845-003-02-1	erlotinib	0.0411523	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.1	erlotinib.1:0.041 uM
M07	BRD-K29415052	BGT-226	trt_cp	10.0 uM	BRD-K29415052-001-01-7	BGT-226	10	uM	DMSO	PGR001	PI3K inhibitor	-666	Forcina2017	C-5001-01-LM6-031	BGT-226	BGT-226:10.0 uM
M08	BRD-K29415052	BGT-226	trt_cp	3.333 uM	BRD-K29415052-001-01-7	BGT-226	3.33333	uM	DMSO	PGR001	PI3K inhibitor	-666	Forcina2017	C-5001-01-LM6-031	BGT-226	BGT-226:3.333 uM
M09	BRD-K29415052	BGT-226	trt_cp	1.111 uM	BRD-K29415052-001-01-7	BGT-226	1.11111	uM	DMSO	PGR001	PI3K inhibitor	-666	Forcina2017	C-5001-01-LM6-031	BGT-226	BGT-226:1.111 uM
M10	BRD-K29415052	BGT-226	trt_cp	0.37 uM	BRD-K29415052-001-01-7	BGT-226	0.37037	uM	DMSO	PGR001	PI3K inhibitor	-666	Forcina2017	C-5001-01-LM6-031	BGT-226	BGT-226:0.37 uM
M11	BRD-K29415052	BGT-226	trt_cp	0.123 uM	BRD-K29415052-001-01-7	BGT-226	0.123457	uM	DMSO	PGR001	PI3K inhibitor	-666	Forcina2017	C-5001-01-LM6-031	BGT-226	BGT-226:0.123 uM
M12	BRD-K29415052	BGT-226	trt_cp	0.041 uM	BRD-K29415052-001-01-7	BGT-226	0.0411523	uM	DMSO	PGR001	PI3K inhibitor	-666	Forcina2017	C-5001-01-LM6-031	BGT-226	BGT-226:0.041 uM
M13	BRD-K49865102	PD-0325901	trt_cp	10.0 uM	BRD-K49865102-001-14-2	PD-0325901	10	uM	DMSO	PGR001	MAP kinase inhibitor|Protein kinase inhibitor|MEK inhibitor	MAP2K1	Chan2013	C-5001-01-LM6-031	PD-0325901	PD-0325901:10.0 uM
M14	BRD-K49865102	PD-0325901	trt_cp	3.333 uM	BRD-K49865102-001-14-2	PD-0325901	3.33333	uM	DMSO	PGR001	MAP kinase inhibitor|Protein kinase inhibitor|MEK inhibitor	MAP2K1	Chan2013	C-5001-01-LM6-031	PD-0325901	PD-0325901:3.333 uM
M15	BRD-K49865102	PD-0325901	trt_cp	1.111 uM	BRD-K49865102-001-14-2	PD-0325901	1.11111	uM	DMSO	PGR001	MAP kinase inhibitor|Protein kinase inhibitor|MEK inhibitor	MAP2K1	Chan2013	C-5001-01-LM6-031	PD-0325901	PD-0325901:1.111 uM
M16	BRD-K49865102	PD-0325901	trt_cp	0.37 uM	BRD-K49865102-001-14-2	PD-0325901	0.37037	uM	DMSO	PGR001	MAP kinase inhibitor|Protein kinase inhibitor|MEK inhibitor	MAP2K1	Chan2013	C-5001-01-LM6-031	PD-0325901	PD-0325901:0.37 uM
M17	BRD-K49865102	PD-0325901	trt_cp	0.123 uM	BRD-K49865102-001-14-2	PD-0325901	0.123457	uM	DMSO	PGR001	MAP kinase inhibitor|Protein kinase inhibitor|MEK inhibitor	MAP2K1	Chan2013	C-5001-01-LM6-031	PD-0325901	PD-0325901:0.123 uM
M18	BRD-K49865102	PD-0325901	trt_cp	0.041 uM	BRD-K49865102-001-14-2	PD-0325901	0.0411523	uM	DMSO	PGR001	MAP kinase inhibitor|Protein kinase inhibitor|MEK inhibitor	MAP2K1	Chan2013	C-5001-01-LM6-031	PD-0325901	PD-0325901:0.041 uM
M19	BRD-K51313569	palbociclib	trt_cp	10.0 uM	BRD-K51313569-001-01-1	palbociclib	10	uM	DMSO	PGR001	CDK inhibitor	CDK4|CDK6	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	palbociclib	palbociclib:10.0 uM
M20	BRD-K51313569	palbociclib	trt_cp	3.333 uM	BRD-K51313569-001-01-1	palbociclib	3.33333	uM	DMSO	PGR001	CDK inhibitor	CDK4|CDK6	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	palbociclib	palbociclib:3.333 uM
M21	BRD-K51313569	palbociclib	trt_cp	1.111 uM	BRD-K51313569-001-01-1	palbociclib	1.11111	uM	DMSO	PGR001	CDK inhibitor	CDK4|CDK6	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	palbociclib	palbociclib:1.111 uM
M22	BRD-K51313569	palbociclib	trt_cp	0.37 uM	BRD-K51313569-001-01-1	palbociclib	0.37037	uM	DMSO	PGR001	CDK inhibitor	CDK4|CDK6	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	palbociclib	palbociclib:0.37 uM
M23	BRD-K51313569	palbociclib	trt_cp	0.123 uM	BRD-K51313569-001-01-1	palbociclib	0.123457	uM	DMSO	PGR001	CDK inhibitor	CDK4|CDK6	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	palbociclib	palbociclib:0.123 uM
M24	BRD-K51313569	palbociclib	trt_cp	0.041 uM	BRD-K51313569-001-01-1	palbociclib	0.0411523	uM	DMSO	PGR001	CDK inhibitor	CDK4|CDK6	120h > 24h in Pr500 pilot	C-5001-01-LM6-031	palbociclib	palbociclib:0.041 uM
N01	BRD-A12230535	nutlin-3	trt_cp	10.0 uM	BRD-A12230535-001-16-6	nutlin-3	10	uM	DMSO	PGR001	MDM inhibitor	MDM2	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	nutlin-3	nutlin-3:10.0 uM
N02	BRD-A12230535	nutlin-3	trt_cp	3.333 uM	BRD-A12230535-001-16-6	nutlin-3	3.33333	uM	DMSO	PGR001	MDM inhibitor	MDM2	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	nutlin-3	nutlin-3:3.333 uM
N03	BRD-A12230535	nutlin-3	trt_cp	1.111 uM	BRD-A12230535-001-16-6	nutlin-3	1.11111	uM	DMSO	PGR001	MDM inhibitor	MDM2	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	nutlin-3	nutlin-3:1.111 uM
N04	BRD-A12230535	nutlin-3	trt_cp	0.37 uM	BRD-A12230535-001-16-6	nutlin-3	0.37037	uM	DMSO	PGR001	MDM inhibitor	MDM2	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	nutlin-3	nutlin-3:0.37 uM
N05	BRD-A12230535	nutlin-3	trt_cp	0.123 uM	BRD-A12230535-001-16-6	nutlin-3	0.123457	uM	DMSO	PGR001	MDM inhibitor	MDM2	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	nutlin-3	nutlin-3:0.123 uM
N06	BRD-A12230535	nutlin-3	trt_cp	0.041 uM	BRD-A12230535-001-16-6	nutlin-3	0.0411523	uM	DMSO	PGR001	MDM inhibitor	MDM2	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	nutlin-3	nutlin-3:0.041 uM
N07	BRD-K29415052	BGT-226	trt_cp	10.0 uM	BRD-K29415052-001-01-7	BGT-226	10	uM	DMSO	PGR001	PI3K inhibitor	-666	Forcina2017	C-5001-01-LM6-031	BGT-226	BGT-226:10.0 uM
N08	BRD-K29415052	BGT-226	trt_cp	3.333 uM	BRD-K29415052-001-01-7	BGT-226	3.33333	uM	DMSO	PGR001	PI3K inhibitor	-666	Forcina2017	C-5001-01-LM6-031	BGT-226	BGT-226:3.333 uM
N09	BRD-K29415052	BGT-226	trt_cp	1.111 uM	BRD-K29415052-001-01-7	BGT-226	1.11111	uM	DMSO	PGR001	PI3K inhibitor	-666	Forcina2017	C-5001-01-LM6-031	BGT-226	BGT-226:1.111 uM
N10	BRD-K29415052	BGT-226	trt_cp	0.37 uM	BRD-K29415052-001-01-7	BGT-226	0.37037	uM	DMSO	PGR001	PI3K inhibitor	-666	Forcina2017	C-5001-01-LM6-031	BGT-226	BGT-226:0.37 uM
N11	BRD-K29415052	BGT-226	trt_cp	0.123 uM	BRD-K29415052-001-01-7	BGT-226	0.123457	uM	DMSO	PGR001	PI3K inhibitor	-666	Forcina2017	C-5001-01-LM6-031	BGT-226	BGT-226:0.123 uM
N12	BRD-K29415052	BGT-226	trt_cp	0.041 uM	BRD-K29415052-001-01-7	BGT-226	0.0411523	uM	DMSO	PGR001	PI3K inhibitor	-666	Forcina2017	C-5001-01-LM6-031	BGT-226	BGT-226:0.041 uM
N13	BRD-K51544265	cabozantinib	trt_cp	10.0 uM	BRD-K51544265-001-10-9	cabozantinib	10	uM	DMSO	PGR001	RET tyrosine kinase inhibitor|VEGFR inhibitor	KDR|MET|FLT3|KIT|RET|TEK	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	cabozantinib	cabozantinib:10.0 uM
N14	BRD-K51544265	cabozantinib	trt_cp	3.333 uM	BRD-K51544265-001-10-9	cabozantinib	3.33333	uM	DMSO	PGR001	RET tyrosine kinase inhibitor|VEGFR inhibitor	KDR|MET|FLT3|KIT|RET|TEK	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	cabozantinib	cabozantinib:3.333 uM
N15	BRD-K51544265	cabozantinib	trt_cp	1.111 uM	BRD-K51544265-001-10-9	cabozantinib	1.11111	uM	DMSO	PGR001	RET tyrosine kinase inhibitor|VEGFR inhibitor	KDR|MET|FLT3|KIT|RET|TEK	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	cabozantinib	cabozantinib:1.111 uM
N16	BRD-K51544265	cabozantinib	trt_cp	0.37 uM	BRD-K51544265-001-10-9	cabozantinib	0.37037	uM	DMSO	PGR001	RET tyrosine kinase inhibitor|VEGFR inhibitor	KDR|MET|FLT3|KIT|RET|TEK	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	cabozantinib	cabozantinib:0.37 uM
N17	BRD-K51544265	cabozantinib	trt_cp	0.123 uM	BRD-K51544265-001-10-9	cabozantinib	0.123457	uM	DMSO	PGR001	RET tyrosine kinase inhibitor|VEGFR inhibitor	KDR|MET|FLT3|KIT|RET|TEK	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	cabozantinib	cabozantinib:0.123 uM
N18	BRD-K51544265	cabozantinib	trt_cp	0.041 uM	BRD-K51544265-001-10-9	cabozantinib	0.0411523	uM	DMSO	PGR001	RET tyrosine kinase inhibitor|VEGFR inhibitor	KDR|MET|FLT3|KIT|RET|TEK	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	cabozantinib	cabozantinib:0.041 uM
N19	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.10	DMSO.10:-666
N20	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.09	DMSO.09:-666
N21	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.04	DMSO.04:-666
N22	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.10	DMSO.10:-666
N23	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.09	DMSO.09:-666
N24	DMSO	DMSO	ctl_vehicle	-666	DMSO	DMSO	-666	-666	DMSO	PGR001	vehicle control	-666	negative control for SSMD	C-5001-01-LM6-031	DMSO.03	DMSO.03:-666
O01	BRD-K88510285	bortezomib	trt_poscon	10.0 uM	BRD-K88510285-001-61-6	bortezomib	10.0016	uM	DMSO	PGR001	NFkB pathway inhibitor|Proteasome inhibitor	PSMB5|PSMB1|PSMB2	positive control for SSMD	C-5001-01-LM6-031	bortezomib.1	bortezomib.1:10.0 uM
O02	BRD-K88510285	bortezomib	trt_poscon	10.0 uM	BRD-K88510285-001-61-6	bortezomib	10.0016	uM	DMSO	PGR001	NFkB pathway inhibitor|Proteasome inhibitor	PSMB5|PSMB1|PSMB2	positive control for SSMD	C-5001-01-LM6-031	bortezomib.1	bortezomib.1:10.0 uM
O03	BRD-K88510285	bortezomib	trt_poscon	10.0 uM	BRD-K88510285-001-61-6	bortezomib	10.0016	uM	DMSO	PGR001	NFkB pathway inhibitor|Proteasome inhibitor	PSMB5|PSMB1|PSMB2	positive control for SSMD	C-5001-01-LM6-031	bortezomib.4	bortezomib.4:10.0 uM
O04	BRD-K88510285	bortezomib	trt_poscon	10.0 uM	BRD-K88510285-001-61-6	bortezomib	10.0016	uM	DMSO	PGR001	NFkB pathway inhibitor|Proteasome inhibitor	PSMB5|PSMB1|PSMB2	positive control for SSMD	C-5001-01-LM6-031	bortezomib.2	bortezomib.2:10.0 uM
O05	BRD-K88510285	bortezomib	trt_poscon	10.0 uM	BRD-K88510285-001-61-6	bortezomib	10.0016	uM	DMSO	PGR001	NFkB pathway inhibitor|Proteasome inhibitor	PSMB5|PSMB1|PSMB2	positive control for SSMD	C-5001-01-LM6-031	bortezomib.4	bortezomib.4:10.0 uM
O06	BRD-K88510285	bortezomib	trt_poscon	10.0 uM	BRD-K88510285-001-61-6	bortezomib	10.0016	uM	DMSO	PGR001	NFkB pathway inhibitor|Proteasome inhibitor	PSMB5|PSMB1|PSMB2	positive control for SSMD	C-5001-01-LM6-031	bortezomib.3	bortezomib.3:10.0 uM
O07	BRD-K70401845	erlotinib	trt_cp	10.0 uM	BRD-K70401845-003-11-2	erlotinib	10	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.2	erlotinib.2:10.0 uM
O08	BRD-K70401845	erlotinib	trt_cp	3.333 uM	BRD-K70401845-003-11-2	erlotinib	3.33333	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.2	erlotinib.2:3.333 uM
O09	BRD-K70401845	erlotinib	trt_cp	1.111 uM	BRD-K70401845-003-11-2	erlotinib	1.11111	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.2	erlotinib.2:1.111 uM
O10	BRD-K70401845	erlotinib	trt_cp	0.37 uM	BRD-K70401845-003-11-2	erlotinib	0.37037	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.2	erlotinib.2:0.37 uM
O11	BRD-K70401845	erlotinib	trt_cp	0.123 uM	BRD-K70401845-003-11-2	erlotinib	0.123457	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.2	erlotinib.2:0.123 uM
O12	BRD-K70401845	erlotinib	trt_cp	0.041 uM	BRD-K70401845-003-11-2	erlotinib	0.0411523	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.2	erlotinib.2:0.041 uM
O13	BRD-A12230535	nutlin-3	trt_cp	10.0 uM	BRD-A12230535-001-16-6	nutlin-3	10	uM	DMSO	PGR001	MDM inhibitor	MDM2	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	nutlin-3	nutlin-3:10.0 uM
O14	BRD-A12230535	nutlin-3	trt_cp	3.333 uM	BRD-A12230535-001-16-6	nutlin-3	3.33333	uM	DMSO	PGR001	MDM inhibitor	MDM2	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	nutlin-3	nutlin-3:3.333 uM
O15	BRD-A12230535	nutlin-3	trt_cp	1.111 uM	BRD-A12230535-001-16-6	nutlin-3	1.11111	uM	DMSO	PGR001	MDM inhibitor	MDM2	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	nutlin-3	nutlin-3:1.111 uM
O16	BRD-A12230535	nutlin-3	trt_cp	0.37 uM	BRD-A12230535-001-16-6	nutlin-3	0.37037	uM	DMSO	PGR001	MDM inhibitor	MDM2	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	nutlin-3	nutlin-3:0.37 uM
O17	BRD-A12230535	nutlin-3	trt_cp	0.123 uM	BRD-A12230535-001-16-6	nutlin-3	0.123457	uM	DMSO	PGR001	MDM inhibitor	MDM2	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	nutlin-3	nutlin-3:0.123 uM
O18	BRD-A12230535	nutlin-3	trt_cp	0.041 uM	BRD-A12230535-001-16-6	nutlin-3	0.0411523	uM	DMSO	PGR001	MDM inhibitor	MDM2	120h = 24h in Pr500 pilot	C-5001-01-LM6-031	nutlin-3	nutlin-3:0.041 uM
O19	BRD-A63610676	paclitaxel	trt_cp	10.0 uM	BRD-A63610676-001-15-8	paclitaxel	10	uM	DMSO	PGR001	Tubulin inhibitor	NR1I2|TUBB	Chan2013	C-5001-01-LM6-031	paclitaxel	paclitaxel:10.0 uM
O20	BRD-A63610676	paclitaxel	trt_cp	3.333 uM	BRD-A63610676-001-15-8	paclitaxel	3.33333	uM	DMSO	PGR001	Tubulin inhibitor	NR1I2|TUBB	Chan2013	C-5001-01-LM6-031	paclitaxel	paclitaxel:3.333 uM
O21	BRD-A63610676	paclitaxel	trt_cp	1.111 uM	BRD-A63610676-001-15-8	paclitaxel	1.11111	uM	DMSO	PGR001	Tubulin inhibitor	NR1I2|TUBB	Chan2013	C-5001-01-LM6-031	paclitaxel	paclitaxel:1.111 uM
O22	BRD-A63610676	paclitaxel	trt_cp	0.37 uM	BRD-A63610676-001-15-8	paclitaxel	0.37037	uM	DMSO	PGR001	Tubulin inhibitor	NR1I2|TUBB	Chan2013	C-5001-01-LM6-031	paclitaxel	paclitaxel:0.37 uM
O23	BRD-A63610676	paclitaxel	trt_cp	0.123 uM	BRD-A63610676-001-15-8	paclitaxel	0.123457	uM	DMSO	PGR001	Tubulin inhibitor	NR1I2|TUBB	Chan2013	C-5001-01-LM6-031	paclitaxel	paclitaxel:0.123 uM
O24	BRD-A63610676	paclitaxel	trt_cp	0.041 uM	BRD-A63610676-001-15-8	paclitaxel	0.0411523	uM	DMSO	PGR001	Tubulin inhibitor	NR1I2|TUBB	Chan2013	C-5001-01-LM6-031	paclitaxel	paclitaxel:0.041 uM
P01	BRD-K08316444	rotenone	trt_cp	10.0 uM	BRD-K08316444-001-03-5	rotenone	10	uM	DMSO	PGR001	Mitochondrial complex I inhibitor	MT-ND1	Harris2016	C-5001-01-LM6-031	rotenone	rotenone:10.0 uM
P02	BRD-K08316444	rotenone	trt_cp	3.333 uM	BRD-K08316444-001-03-5	rotenone	3.33333	uM	DMSO	PGR001	Mitochondrial complex I inhibitor	MT-ND1	Harris2016	C-5001-01-LM6-031	rotenone	rotenone:3.333 uM
P03	BRD-K08316444	rotenone	trt_cp	1.111 uM	BRD-K08316444-001-03-5	rotenone	1.11111	uM	DMSO	PGR001	Mitochondrial complex I inhibitor	MT-ND1	Harris2016	C-5001-01-LM6-031	rotenone	rotenone:1.111 uM
P04	BRD-K08316444	rotenone	trt_cp	0.37 uM	BRD-K08316444-001-03-5	rotenone	0.37037	uM	DMSO	PGR001	Mitochondrial complex I inhibitor	MT-ND1	Harris2016	C-5001-01-LM6-031	rotenone	rotenone:0.37 uM
P05	BRD-K08316444	rotenone	trt_cp	0.123 uM	BRD-K08316444-001-03-5	rotenone	0.123457	uM	DMSO	PGR001	Mitochondrial complex I inhibitor	MT-ND1	Harris2016	C-5001-01-LM6-031	rotenone	rotenone:0.123 uM
P06	BRD-K08316444	rotenone	trt_cp	0.041 uM	BRD-K08316444-001-03-5	rotenone	0.0411523	uM	DMSO	PGR001	Mitochondrial complex I inhibitor	MT-ND1	Harris2016	C-5001-01-LM6-031	rotenone	rotenone:0.041 uM
P07	BRD-K70401845	erlotinib	trt_cp	10.0 uM	BRD-K70401845-003-02-1	erlotinib	10	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.2	erlotinib.2:10.0 uM
P08	BRD-K70401845	erlotinib	trt_cp	3.333 uM	BRD-K70401845-003-02-1	erlotinib	3.33333	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.2	erlotinib.2:3.333 uM
P09	BRD-K70401845	erlotinib	trt_cp	1.111 uM	BRD-K70401845-003-02-1	erlotinib	1.11111	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.2	erlotinib.2:1.111 uM
P10	BRD-K70401845	erlotinib	trt_cp	0.37 uM	BRD-K70401845-003-02-1	erlotinib	0.37037	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.2	erlotinib.2:0.37 uM
P11	BRD-K70401845	erlotinib	trt_cp	0.123 uM	BRD-K70401845-003-02-1	erlotinib	0.123457	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.2	erlotinib.2:0.123 uM
P12	BRD-K70401845	erlotinib	trt_cp	0.041 uM	BRD-K70401845-003-02-1	erlotinib	0.0411523	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.2	erlotinib.2:0.041 uM
P13	BRD-K70401845	erlotinib	trt_cp	10.0 uM	BRD-K70401845-003-11-2	erlotinib	10	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.2	erlotinib.2:10.0 uM
P14	BRD-K70401845	erlotinib	trt_cp	3.333 uM	BRD-K70401845-003-11-2	erlotinib	3.33333	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.2	erlotinib.2:3.333 uM
P15	BRD-K70401845	erlotinib	trt_cp	1.111 uM	BRD-K70401845-003-11-2	erlotinib	1.11111	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.2	erlotinib.2:1.111 uM
P16	BRD-K70401845	erlotinib	trt_cp	0.37 uM	BRD-K70401845-003-11-2	erlotinib	0.37037	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.2	erlotinib.2:0.37 uM
P17	BRD-K70401845	erlotinib	trt_cp	0.123 uM	BRD-K70401845-003-11-2	erlotinib	0.123457	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.2	erlotinib.2:0.123 uM
P18	BRD-K70401845	erlotinib	trt_cp	0.041 uM	BRD-K70401845-003-11-2	erlotinib	0.0411523	uM	DMSO	PGR001	EGFR inhibitor	EGFR	Harris2016	C-5001-01-LM6-031	erlotinib.2	erlotinib.2:0.041 uM
P19	BRD-K15616905	CCCP	trt_cp	10.0 uM	BRD-K15616905-001-03-1	CCCP	10	uM	DMSO	PGR001	Mitochondrial oxidative phosphorylation uncoupler	-666	Forcina2017	C-5001-01-LM6-031	CCCP	CCCP:10.0 uM
P20	BRD-K15616905	CCCP	trt_cp	3.333 uM	BRD-K15616905-001-03-1	CCCP	3.33333	uM	DMSO	PGR001	Mitochondrial oxidative phosphorylation uncoupler	-666	Forcina2017	C-5001-01-LM6-031	CCCP	CCCP:3.333 uM
P21	BRD-K15616905	CCCP	trt_cp	1.111 uM	BRD-K15616905-001-03-1	CCCP	1.11111	uM	DMSO	PGR001	Mitochondrial oxidative phosphorylation uncoupler	-666	Forcina2017	C-5001-01-LM6-031	CCCP	CCCP:1.111 uM
P22	BRD-K15616905	CCCP	trt_cp	0.37 uM	BRD-K15616905-001-03-1	CCCP	0.37037	uM	DMSO	PGR001	Mitochondrial oxidative phosphorylation uncoupler	-666	Forcina2017	C-5001-01-LM6-031	CCCP	CCCP:0.37 uM
P23	BRD-K15616905	CCCP	trt_cp	0.123 uM	BRD-K15616905-001-03-1	CCCP	0.123457	uM	DMSO	PGR001	Mitochondrial oxidative phosphorylation uncoupler	-666	Forcina2017	C-5001-01-LM6-031	CCCP	CCCP:0.123 uM
P24	BRD-K15616905	CCCP	trt_cp	0.041 uM	BRD-K15616905-001-03-1	CCCP	0.0411523	uM	DMSO	PGR001	Mitochondrial oxidative phosphorylation uncoupler	-666	Forcina2017	C-5001-01-LM6-031	CCCP	CCCP:0.041 uM
